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To my family.
”The whole problem with the world is that fools and fanatics are always so
certain of themselves, but wiser people so full of doubts.”
-Bertrand Russel, 1872-1970
ABSTRACT
Positron emission tomography (PET) is a medical imaging modality with which neu-
rophysiological functions can be studied. After a radio-labeled molecule is injected intra-
venously, it is transported by the blood stream to the target of interest. The radioactive atom
of the molecule decays, resulting in two gamma rays that the PET system detects. Based
on this measurement, an image can be reconstructed displaying the distribution of the radi-
oligand, which in turn provides useful information regarding the underlying physiology.
This thesis focuses on methodological advancements in the quantification of PET
data obtained from neurological studies. The work included in the thesis can be catego-
rized into three sections. Section 1 comprises two studies (Study I and II) and focuses
on the effect of the resolution of the PET system when quantifying the data. When us-
ing PET to study brain functions in for instance the brainstem, the structures of interest
are small and therefore presumably affected by resolution. The results of study I showed
that, using conventional methods for PET data analysis, the difference obtained between
two PET systems with different resolution can be compensated for by applying algorithms
that artificially compensate for resolution-induced image artifacts. This is an interesting
finding as it enables data acquired in two different PET systems to be pooled into the same
analysis, without introducing significant bias. In study II, we found that using a high reso-
lution PET system, in combination with a noise suppression technique and a semiautomatic
procedure to define regions of interests (ROIs), it is possible to accurately quantify radi-
oligand binding in very small brain structures. The procedure allows for detailed mapping
of the distribution of serotonin transporter in the brainstem, and may thus be used to help
elucidate the role of the serotonin system in central nervous system disorders.
Section 2 targets the definition of ROIs required for analysis of PET data. Conven-
tionally, ROIs are defined manually by a neuranatomically trained expert on MR images
acquired from the same subject. This procedure is time consuming and introduces a large
amount of user interaction in the data analysis, making it prone to rater bias. In study III, it
is shown that manual ROIs can reliably be replaced with automated versions provided by
the software package FreeSurfer or the Automated Anatomical Labeling (AAL) template.
These automated methods provide objective and reproducible analysis of PET data.
In section 3, a new method to cluster the voxels of PET images is presented. This
Pair-Wise Correlation (PWC) approach groups correlating voxels, either within or across
subjects. The method is used for two different purposes. First, in study IV, the PWC method
isolates the signal corresponding to arterial blood in the images. This image-derived blood
signal provides the possibility to quantify PET data without measuring the radioactivity
level in arterial blood, which significantly reduces the invasiveness during a PET examina-
tion. Second, in study V, the PWC method identifies a disease-specific pattern of amyloid-β
plaque in patients with Alzheimer’s disease. The pattern can in turn separate a group of AD
patients from control subjects, suggesting that the PWC method may aid for early and ob-
jective detection of brain amyloid.
In conclusion, this thesis focused on validation and implementation of advanced tools
for quantification of PET data. The results indicate that the methods included in this thesis
provide improved quantification of PET data and can be used in clinical PET studies.
SAMMANFATTNING
Utvecklingen av medicinsk avbildning har under de senaste decennierna gjort an-
märkningsvärda framsteg. Idag kan man studera såväl strukturer som funktioner av krop-
pens inre organ med mycket hög upplösning och känslighet. Olika avbildningsmetoder
erbjuder olika sorters information, och kan ofta samverka till synergistiska effekter. För
att studera strukturella förändringar i kroppen, till exempel vid benbrott eller hjärnblöd-
ning, kan magnetresonanstomografi (MR) eller datortomografi användas. Dessa avbild-
ningstekniker tillhandahåller dock ingen information om kroppens funktion, d.v.s cellulära
mekanismer såsom energikonsumption, syresättning och kommunikation mellan nervceller.
Positronemissionstomografi (PET) är en funktionell eller molekylär avbildningsme-
tod. PET bygger på att spårmolekyler administreras i kroppen, varpå den strålning som
molekylerna ger upphov till registreras av PET-kameran. På så sätt kan distributionen av
spårmolekylen i kroppen mätas, och med kunskap om spårmolekylens biologiska egen-
skaper kan slutsatser om kroppens funktioner dras.
Denna avhandling syftar till att förbättra de metoder som används för att kvantifiera
PET-mätningar. Avhandlingen är indelad i tre delar. Del ett fokuserar till stor del på de
begränsningar som PET-kamerans relativt dåliga upplösning sätter på kvantifieringen av
PET data. I del ett visas bl.a. att förbättringar i upplösning från ∼4 mm till ∼2 mm min-
skar mätfelet, och att man med hjälp av algoritmer som artificiellt höjer bildupplösningen
kan kompensera för den skillnaden. Den senare upptäckten möjliggör därmed att PET-data
insamlad med olika system kan kombineras i samma studie, vilket underlättar exempelvis
forskning bedriven vid flera forskningscentrum. Vidare så visas i del ett att PET-kameror
med väldigt hög upplösning, tillsammans med metoder som förtrycker mätbrus kan använ-
das för att kvantifiera koncentrationer av radioliganden i mycket små strukturer i hjärnan,
vilket möjliggör detaljerad kartläggning av bl.a. hjärnstammens fysiologi.
I del två i avhandlingen så utvärderas två metoder för automatisk avgränsning av de
hjärnregioner som ska inkluderas i analysen. Traditionellt sett så görs dessa avgränsningar
manuellt, genom att regionerna ritas på MR-bilder. Ett sådant förfarande är dock begränsat
av en rad faktorer. Bland annat medför det en stor del användarinteraktion, vilket kan
introducera systematiska fel. Dessutom är det tidskrävande och försvårar därmed analys
av stora mängder data. I del två påvisas att automatiska avgränsningsmetoder kan ersätta
manuella, och därmed kan ovan nämnda begränsningar undvikas.
I del tre så beskrivs en helt ny metod för att representera PET-data. Metoden byg-
ger på att alla parvisa korrelationer mellan PET-bildens bildpunkter beräknas, och sparas
i en stor matris. På så sätt kan alla punkter som korrelerar med varandra identifieras, och
specifika nätverk i hjärnan kan kartläggas. Metoden användes först för att identifiera bild-
punkter som innehåller blod, för att på så sätt kringå behovet av att sätta artärnål under
PET-mätningar. Sedan applicerades metoden på en grupp patienter med Alzheimer’s sjuk-
dom (AD) för att kartlägga hur de patologiska utfällningarna av s.k. amyloida plack var
distribuerade i hjärnan. De kluster av amyloid som identifierades kunde sedermera använ-
das för att på ett objektivt sätt och med goda marginaler separera en annan grupp patienter
med AD från friska kontroller. Den föreslagna proceduren har således potential att under-
lätta ställandet av tidiga diagnoser, samt indikera huruvida individer befinner sig i riskzonen
för att utveckla AD.
Sammanfattningsvis så innehåller avhandlingen utveckling och utvärdering av en rad
metodologiska verktyg för analys av PET-data. Resultaten visar att dessa metoder medför
förbättrad metodologi, och att de med fördel kan användas i kliniska studier.
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1 INTRODUCTION
1.1 Rationale for this thesis
The evolution of medical imaging techniques has had a major impact on healthcare in the
industrialized part of the world. The ability to visualize internal anatomy and physiology
is frequently used today for both diagnostic and research purposes, at a steadily increasing
rate. Until 2010, approximately 5 billion medical imaging investigations had been con-
ducted worldwide, of which two thirds employed ionizing radiation [1]. Each of these
measurements is associated with a cost, both from the biological impact of radiation on the
human body, and economically. Methods used for analyzing the images must therefore be
of the highest possible standard, in terms of providing reliable results and maximizing the
amount of information extracted from each image.
Methodological development in medical science is however a never-ending task. The
exponential improvement of processor power acquired over the last 60 years [2], together
with advancements in related scientific disciplines such as physics and signal processing,
enables a continuous refinement of imaging methodology. For positron emission tomog-
raphy (PET), such advancements include improved detectors [3, 4] and system electronics
[5], enhanced reconstruction strategies [6] to reduce the measurement noise and maintain-
ing high resolution, as well as improved statistical tools for group analysis such as data
mining [7] and clustering approaches [8]. Such analysis tools have during recent years
gained remarkable attention in scientific communities. Today, hospitals and universities
possess large archives of medical data, and these biobanks are predicted to be the core re-
sources of medical research in the 21th century [9]. Possible applications of such resources
are scientific group analysis with such statistical power that novel insights of biology can
be gained, and systems that support clinical decisions [10] and treatment planning [11].
Both of these examples require that data acquired in various settings and locations
can be directly compared. Measurements acquired on different systems, and analysis pro-
cedures relying to a large extent on manual user interaction, may prevent an unbiased pool-
ing or comparison of data. It is therefore of important that measurement errors induced by
the system are well understood and corrected, and that objective analysis approaches are
available.
The general aim of this thesis was to develop and evaluate methodological tools for
standardized and user-independent quantification of data acquired with PET. In study I,
we investigated the difference in serotonin transporter density estimated from PET images
acquired on PET systems with different resolutions, and showed that algorithms compen-
sating for resolution-induced image artifacts could reduce that difference. This observa-
tion suggests that images from the two systems can be pooled into the same analysis, and
thereby simplifies multi-center studies. In study II we developed a method that permits the
quantification of serotonin transporter availability in the brainstem in a standardized way.
In study III, we evaluated automated methods for objective definition of region of interests
(ROIs). Automated definition of ROIs greatly reduces the time required for performing
PET data analysis and reduces the need for user interaction in the analysis. In study IV, we
developed a method for non-invasive measurement of the radioactivity concentration in the
blood that can simplify the quantification procedure of PET data. Finally, in study V, we
demonstrated how statistical approaches can be used to identify disease specific patterns in
PET images acquired from a group of patients with Alzheimer’s disease.
1
1.2 Applications of PET for neuroscience research
Unlike structural imaging modalities such as magnetic resonance imaging or computed
tomography, PET is a functional imaging modality that measures brain function. More
specifically, PET enables estimation of physiological parameters, such as density of neu-
rotransmitter receptors or transporters, blood flow, glucose metabolism, oxygen utilization,
and neuroinflammation. The ability to study such functional processes in the brain in vivo
has provided new knowledge in several fields of clinical neuroscience, including neurode-
generative diseases such as Alzheimer’s disease [12], psychiatric disorders such as major
depression [13], and cognitive neuroscience [14, 15]. Moreover, the possibility to measure
changes in various neurotransmitter systems in vivo has made PET a valuable tool for psy-
chiatric drug research, as the technique enables accurate quantification of drug delivery and
occupancy of the target of interest [16].
1.3 PET methodology
1.3.1 Radioactive nuclides
The acquisition of PET data relies upon the decay of certain unstable isotopes such as
11C, 18F, 13N, and 15O. When these isotopes decay, a positron is created and emitted. A
radioligand – a molecule in which one of the atoms is replaced by a radioactive isotope – is
used as imaging marker. The properties of the molecule determines the target site to which
the radioligand will bind. For instance, raclopride is a synthetic compound, which binds
to the dopamine D2 receptor, that can be combined with 11C (denoted [11C]raclopride) to
measure the dopamine D2 receptor availability in vivo. Examples of other radioligands
include [11C]MADAM which binds to the serotonin transporter, [11C]flumazenil which
binds to the GABAA receptor, and [11C]PiB which binds to amyloid β-plaques, expressed
in the brains of patients with Alzheimer’s disease (AD).
1.3.2 PET data acquisition
Figure 1. An unstable nucleus decays, producing
a positron which in turn interacts with an electron.
The annihilation of the two particles produces a pho-
ton pair.
A PET radioligand is normally administered
intravenously and delivered via the blood
stream to the target organ, such as the brain.
As the radioactive atom attached to the ra-
dioligand decays, it releases a positron that
travels a short distance (approximately 1 mm,
depending on the isotope, see section 1.3.4)
before interacting with an electron. Upon in-
teraction, the particle pair annihilates, and a
photon pair is created (Figure 1). The en-
ergy conserved in the masses of the electron-
positron pair (1.02 MeV) defines the wave-
length of the photons, which are emitted in a
random direction and separated by approxi-
mately 180o± 0.25o [17]. The uncertainty of
the exact angle is called the non-collinearity
effect, and its extent depends upon the isotope used (see further section 1.3.4).
2
The two photons propagate through tissue, skull, and air, and are eventually detected
by an opposing pair of detectors in the PET system. The Line Of Response (LOR) is
defined as the imaginary straight line connecting the detectors, and it is assumed that the
radioactive decay occurred somewhere along that line. The simultaneous detection of the
two photons is referred to as a coincident count, a somewhat unusual interpretation of the
word coincidence. During a PET measurement, a substantial amount of LORs are recorded
by the PET system, forming the basis upon which the PET image can be reconstructed (see
section 1.3.3)
1.3.3 PET data reconstruction
The PET system records photon pairs created by the annihilation of the positron-electron
pairs. Thus, information obtained from the acquisition consists of projections from the
three dimensional object positioned in the system upon the array of detectors surrounding
that object. The word tomography is derived from the Greek word tomos, meaning a slice or
a disk, and graphein, meaning to write. Accordingly, PET image reconstruction algorithms
recreate the object giving rise to the measured projections by reconstructing a set of 2D
images (slices) which, when stacked on top of each other, compose the reconstructed 3D
image. The projection p of a slice onto the detector is composed by the line integral for all
parallel LORs for each angle θ, as illustrated in figure 2. The position of each LOR in the
Figure 2. The 1D projection p of the 2D object f(x, y) for a certain angle θ. The projections of all angles
are stored in the sinogram, illustrated to the right.
bundle of rays is given by s. Using this nomenclature, the transform of f(x, y) → p(s, θ)
can be obtained using the Radon transform,
p(s, θ) =
∫ ∞
−∞
∫ ∞
−∞
f(x, y)δ(x cos(θ) + y sin(θ)− s)dxdy. (1)
Based upon the projection p, different strategies can be employed in order to recreate
f(x, y). This thesis will only discuss the filtered back projection approach (FBP) and the
ordered subset expectation maximization (OSEM) approach, as all data included in the
thesis are reconstructed using one of these two methods.
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Filtered backprojection The filtered backprojection (FBP) is an analytical solution which
maps the projections back onto the image domain to recreate the object, p(s, θ)→ f(x, y).
The central slice theorem states that the 1D fourier transform of a projection at a certain
angle is equivalent to a line profile through the 2D fourier transform of the object through
the same angle. Therefore, by fourier transforming all projections, letting the transformed
projections fill the 2D fourier space at all angles, and finally applying the inverse 2D fourier
transform, the original object is reconstructed. Since fourier space is filled radially, the in-
formation will not be evenly distributed. Information at the center of the fourier space will
be oversampled, and more sparse closer to the edges. In order to compensate for this in-
homogeneous distribution of data, each projection is filtered prior to being positioned in
the 2D fourier space. In theory, a normal ramp filter solves the oversampling issue by sup-
pressing the central fourier space and amplifying the edges. Mathematically, the filtered
projection pf (s, θ) is given by
pf (s, θ) = F
−1(|h| ·F (p(s, θ))), (2)
where F denotes the fourier transform, |h| is the 1D ramp filter, and p(s, θ) is defined in
equation 1. Once the filtered projections are calculated, the 2D object f(x, y) is obtained
from the filtered backprojection formula,
f(x, y) =
∫ pi
0
pf (s, θ)dθ. (3)
One caveat of the FBP reconstruction approach is that since the ramp filter amplifies
the signal in the edges of the fourier space, it amplifies the high frequent noise. This makes
the reconstruction problem ill-posed, and regularizations have been introduced to stabilize
the algorithm with regards to noisy data. For instance, the Hann window function can be
used as an apodizing function that acts as a low-pass filter to suppress the amplified noise
component.
Ordered Subset Expectation Maximization The OSEM algorithm is an iterative recon-
struction method based upon the maximum likelihood expectation maximization (ML-EM)
method of statistics. It requires that the system matrixH is known, where elementHi,j con-
tains the probability of a photon emitted from voxel j to be detected in projection i. The
reconstruction problem thus takes the form P = HX , where P is the measured projections
andX is the image to be reconstructed, represented as a single column matrix. The number
of photons emitted from voxel j towards projection i is modeled as a Poisson-distributed
stochastic variable, which enables a formulation describing the probability relation between
the measured projections and the true activity in j. Maximizing the expectation value of the
probability function results in the following update rule for the estimated activity in voxel
j,
xnewj =
xcurrentj∑
iHi,j
∑
i
{
Hi,j
pi∑
kHi,kx
current
k
}
, (4)
where pi is the measurement made in the i:th projection. Conceptually, equation 4 describes
that the current estimates of the voxel values are forward-projected to sinogram space
(
∑
kHi,kx
current
k ). Secondly, the ratio between measured projections and the forward-
projected estimates in the voxels are calculated,
(
pi∑
kHi,kx
current
k
)
. This ratio illustrates
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how well the estimated image corresponds with the measured projections. Thirdly, the ra-
tio is backprojected into image space,
(∑
iHi,j
pi∑
kHi,kx
current
k
)
, and finally multiplied by
the current estimate in voxel j, resulting in equation 4 [18].
One drawback of the traditional ML-EM reconstruction is that it requires many itera-
tions before convergence is obtained, resulting in a long reconstruction time. OSEM solves
this issue by categorizing the projections into subsets, and then utilizing only one subset at
a time in equation 4. For instance, the initial image estimate is normally just an array of
constant values, which together with the projections stored in subset 1, is used to create a
first image estimate. This estimate is in turn used as input in equation 4, together with the
projections stored in subset 2. The updated image will be used again as an input, together
with the projections stored in subset 3, and so on, until allN subsets have been used, which
defines one iteration. The subsets of projections are interlaced. For example, if there exist
a total of 9 projections and 3 subsets, subset 1 will include projection 1, 4 and 7; subset
two will include projection 2, 5, and 8; and subset 3 will hold projections 3, 6, and 9. For
the HRRT at Karolinska Institutet, 10 iterations in combination with 16 subsets provide
an optimal trade-off between high recovery of radioactivity and short reconstruction times
[19].
1.3.4 Resolution of PET images
Despite the major improvements achieved in PET image acquisition and reconstruction dur-
ing the last decade, the resolution of PET images are still significantly lower than in struc-
tural imaging modalities such as CT and MRI. Radioactive decay is a Poisson-distributed
stochastic process, and hence, a certain degree of noise already exists at the level of the
decay of the nuclei. Furthermore, the PET system measures the LOR through which the
annihilation of the positron-electron pair occurred. However, the positron created during
a decay event has a certain level of kinetic energy and will travel a short distance before
it annihilates. Thus there will be a discrepancy between position of the annihilation and
the position of the decay, where the latter is of primary interest. The distance between two
events depends on the energy of the positron, which varies for different radionuclides. For
the nuclides commonly used in PET, i.e. 11C and 18F, the average energy is in the order of
a few hundred keV, giving rise to distances of up to 1 mm [20–23].
The positron-electron pair will experience a momentum prior to annihilation. The
principle of conservation of momentum leads to an uncertainty in the exact angle separating
the two emerging photons, which is called the non-collinearity effect [24]. The extent to
which the non-collinearity effect impacts PET images cannot easily be assessed. In 1965,
Colombino et al. approximated that the angular deviation from 180◦ follows a Gaussian
distribution with 0.47◦ FWHM [25]. This number is often referenced to, despite that the
measurement was conducted in pure water and that the chemical properties of the human
body might influence the angular distribution. In more biologically relevant conditions,
the angular deviation from 180◦ may in fact be approximately 10% higher than in water
[26]. In addition to the deviation from 180◦, the actual measurement error due to the non-
collinearity of the photons depends on the diameter of the detector ring.
Apart from the positron travel and non-collinearity effect, the measurement of coin-
cident photon pairs are also affected by random and scattered events, as shown in figure 3.
During a PET examination, the fraction of scattered events can be up to 50% of the total
counts [27]. It is however impossible to determine whether an event is scattered or not,
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Figure 3. The ideal coincidence is shown in the left panel. The other panels illustrate the erroneous LOR
resulting from a scattered event (middle panel), and a random coincidence (right panel).
as long as the energies of the photons are within the energy window of the system. The
correction for scatter is therefore performed by removing the estimated scattered fraction
from the projection. Different strategies have been suggested for estimating fraction of
scattered events. An accurate but computationally expensive alternative has proven to be
Monte Carlo simulation of the scattered photons [28]. Other suggested approaches are the
Gaussian fit method [29] and the single scatter simulation method [30]. For the HRRT at
KI, the scatter distribution is assumed to be Gauss-shaped, and the contribution is estimated
by modifying the function parameters. The parameters are found iteratively by comparing
the measured radioactivity in a region close to the edge and a region in the center of a uni-
formly filled cylindrical phantom. The iteration stops when similar radioactivity values are
obtained in both regions.
The right panel of figure 3 illustrates a LOR generated after a random coincidence,
i.e., a LOR generated after detection of two photons not originating from the same decay.
To minimize the rate of random events (R), a short time window is used during which
two detected photons are considered coincident. Moreover, R can be estimated directly by
recording rates of single events (i.e., detection of only one photon).
As a γ− ray propagates through tissue and skull, its intensity I is attenuated accord-
ing to the Beer-Lambert law,
I(x) = I0e
− ∫ x0 µ(x)dx. (5)
If the attenuation coefficient µ is known for every point in the image, the attenuation of
the rays can be compensated for. Normally a transmission scan precedes the emission
acquisition in order to retrieve the so-called µ-map. The transmission is performed either
with a single source (as in the case of the HRRT) or with rotating rod sources (as in the
case in the ECAT HR system). Either way, the decay of the sources produces γ rays with
energies similar to those produced after an annihilation, so that they are within the system’s
energy window. The µ-map can then be reconstructed in order to retrieve the scaling factors
needed to compensate for the signal attenuation in the PET image.
Clearly, the final resolution of a PET image is affected by several parameters. In ad-
dition to the physical entities discussed above, electronic noise from the circuits, detector
dead time, and intrinsic radioactivity in some scintillators also impact the PET image res-
olution. It has been suggested that, for a given detector size d, detector array diameter D,
positron travel distance r, and additional factors (such as gaps between the detecor blocks),
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the resolution Γ of a PET system can be predicted by
Γ = ξ
√(
d
2
)2
+ (0.0022D)2 + r2 + b2, (6)
where the value of ξ is determined by the reconstruction, and empirically found to be≈ 1.25
[31]. This is interpreted as, if an infinitesimal point source was positioned in the system, the
resulting PET image would be blurred to the extent that if a line profile was drawn through
the blurred point source, it would display a FWHM of Γ mm. The spreading of the point
source is called a point spread function (PSF). The FWHM of the PSF is conventionally
used as a measure of PET system resolution, and is typically in the order of a few mm.
1.3.5 Region of interest analysis
In many PET applications, accurate quantification requires information regarding the ki-
netic properties of a radioligand. The measurement is therefore conducted over time inter-
val; normally 60-90 minutes post radioligand delivery, during which both the uptake and
washout of the compound can be studied. Dynamic PET data are therefore 4D images,
where the fourth dimension typically consists of 20-40 time steps (called time frames). Re-
gional time activity curves (TACs) are obtained by placing a region of interest (ROI) over
a set of image elements (voxels), and calculating the average voxel value for those voxels,
at each time step. The regional TAC will then contain information regarding the temporal
behavior of the radioligand in the specific region. Due to the poor spatial resolution of PET,
images from other modalities, such as MRI or CT, are normally used to define the ROIs.
The ROIs are normally delineated manually on the MR images and then applied to the PET
images. Manual ROI delineation is however associated with several problems, which are
discussed further in section 1.4.4.
1.3.6 Kinetic modeling
The overall objective of quantitative analysis of PET data is to determine a mathematical
model that describes the measured regional TACs and that differentiates the radioligand
concentration in various tissue pools (or compartments). Depending on the properties of
the radioligand, a different number of compartments is required (see figure 4 for the most
commonly used models). For all models, the radioligand concentration in arterial plasma,
Cp, serves as a driving force, or the model’s input.
Figure 4. Common kinetic models used for quantitative analysis of PET data. a: 2-tissue compartment
model, where CND denotes concentration of non-displaceable radioligand (i.e., free and non-specifically
bound), and CS denotes concentration of specifically bound radioligand. For radioligands with rapid transfer
between CND and CS , the model can be simplified to the 1-tissue compartment model, shown in b.
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Regardless of which method is used, the concentration measured in an ROI contains
contribution from all tissue pools and from the radioligand in the vascular tissue within the
ROI. Based on the assumptions introduced by the models and on the Fick principle, a set
of differential equations can be formulated describing the transfer of the radioligand be-
tween the compartments. The solution to these equations provides an analytical expression
describing the concentration of radioligand that is specifically bound to the target site over
time,
CS(t) = Cp(t)⊗
N∑
n=1
ane
−bnt. (7)
The number of exponentials with which the input function Cp(t) is convolved depends on
which model is used, typically one exponential per compartment [32]. In equation 7, the
term
∑N
n=1 ane
−bnt is said to be the impulse response function (IRF). For the special case
of 1TCM, the IRF is K1e−k2t, with the rate constants defined by figure 4. For the other
models, the coefficients an and bn corresponds to combinations of rate constants. Exact
values for an and bn can be estimated by fitting equation 7 to the measured TAC.
A common measure of interest is the total distribution volume, VT . The distribution
volume is defined as the amount of plasma required to account for the amount of radioli-
gand in 1 cm3 of brain tissue [33]. Mathematically, VT is defined as ratio at equilibrium
between total tracer concentration in tissue to that in plasma, and can be calculated as a
combination of the rate constants. VT may also be determined using graphical analysis ap-
proaches, such as the Logan plot [34], which can be derived directly from the differential
equations obtained from the 1TCM or the 2TCM. After applying the fundamental theorem
of calculus and rearranging, the following expression is obtained∫ t
0
CT (τ)dτ
CT (t)
= VT
∫ t
0
Cp(τ)dτ
CT (t)
− 1
k2
. (8)
The plot
∫ t
0 CT (τ)dτ
CT (t)
versus
∫ t
0 Cp(τ)dτ
CT (t)
will become linear after a certain time, normally de-
noted t∗. The slope of the linear curve equals VT [32]. Since this procedure requires
measurement of Cp, it is sometimes referred to as the invasive Logan plot. Fitting a linear
curve is far less computationally demanding than iterative fitting techniques required to
fit equation 7, which renders graphical analysis approaches suitable for the generation of
parametric images (see further section 1.3.7).
Another important parameter for neuroreceptor studies is the ratio k3
k4
from the 2TCM
in figure 4, which is related to the binding potential (BP). BP provides an important the-
oretical connection between imaging and in vitro receptor binding, via BP = B
F
= Bmax
KD
,
where B denotes the concentration of bound receptors, F the concentration of free radioli-
gand, Bmax the total receptor density, and 1KD the binding affinity of the radioligand [35].
In vitro, both B and F can be measured, while in PET imaging, the concentration of free
radioligand is not available. Instead, a common parameter of interest is the BPND, defined
as
BPND =
CS
CND
= fND
CS
CF
= fND
Bmax
KD
(9)
where fND denotes the fraction of the non-displaceable compartment corresponding to free
radioligand (CF = fNDCND, see figure 4a).
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It is possible to calculate BPND directly from the kinetic rate constants in figure 4.
The differential equation for the specifically bound compartment in the 2TCM is
dCS(t)
dt
= k3CND(t)− k4CS(t), (10)
which, at equilibrium, results in CS
CND
= k3
k4
. Since equation 9 states that BPND = CSCND ,
BPND =
k3
k4
. (11)
Regardless of whether the goal is to estimate the individual rate constants or only the
VT , the radioactivity concentration in arterial plasma, Cp(t) needs to be known. However,
if there is a region in the brain which is devoid of the target neuroreceptor, that region can
serve as a reference in which CND can be measured and thereby enable estimation ofBPND
without any knowledge of Cp. The most common reference region models are shown in
figure 5.
Figure 5. Kinetic models using concentration in reference tissue, CR, as an indirect input function. a: 4
parameter reference tissue model. b: Simplified reference tissue model.
Based on the 4 parameter reference tissue model [36] shown in figure 5a, it is possible
to derive a relationship between CT and CR, including the 6 rate constants. However, the
two rate constantsK1 andK ′1 only appear as a ratio. Therefore Lammertsma and colleagues
defined R1 = K1K′1 and assumed that the volume of distribution of the non-specifically bound
tracer is the same in the target and in the reference region,
K1
k2
=
K ′1
k′2
−→ k′2 =
k2K
′
1
K1
=
k2
R1
. (12)
This modification reduced the number of fitting parameters to 4: R1, k2, k3, and BPND
(= k3
k4
).
The four parameter reference tissue model is stable in the estimates of BPND, but
the reliability of the other parameters is limited [37]. For radioligands that can be properly
described by the 1TCM, and for which a proper reference region exists, the 4 parameter
reference tissue model can be simplified even further, into the simplified reference tissue
model (SRTM), shown in figure 5b. The equation describing the radioligand concentration
becomes
CT (t) = R1CR(t) +
{
k2 − R1k2
1 +BPND
}
CR(t)⊗ e−
k2t
1+BPND , (13)
where the three unknown parameters R1, k2, and BPND are estimated via fitting.
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Lastly, the Logan plot can also be modified so that it utilizes a reference region instead
of the measured radioactivity in plasma [38]. By applying equation 8 to the reference
region CR, an analytical expression for Cp as a function of CR can be obtained. Inserting
that expression back into equation 8 results in following the expression∫ t
0
CT (τ)dτ
CT (t)
= DVR
∫ t
0
CR(τ)dτ
CT (t)
+ intercept. (14)
Similarly to the invasive Logan plot, the slope of the linear part of the plot
∫ t
0 CT (τ)dτ
CT (t)
versus∫ t
0 CR(τ)dτ
CT (t)
holds the parameter of interest, in this case the distribution volume ratio, DVR =
VT
VND
= BPND+1. Logan plot using a reference region rather than blood samples is referred
to as the non-invasive Logan plot.
1.3.7 Parametric mapping
Conventional methods of analyzing PET data perform the quantification on the ROI level,
i.e., the parameter of interest, such as VT or BPND, is calculated for each ROI. Conse-
quently, all information about heterogeneity of radioligand binding within the ROI is lost.
Attractive alternatives are parametric mapping approaches. These algorithms calculate a
value for the outcome measure in each voxel and thereby creates 3D maps of parameter
distribution (see figure 6).
Figure 6. Parametric images showing the distribution of binding potential of [11C]MADAM (binding to the
serotonin transporter) acquired with the HR and the HRRT system.
Estimating outcome measures at the voxel level is associated with a high computa-
tional cost. Therefore, due to the non-linear fitting procedures, compartmental modeling
has not proven to be a viable strategy for generation of parametric maps. Moreover, since
the TAC of each voxel is associated with a high noise level, the algorithm needs to apply
noise reduction filters in order to derive meaningful estimates. Examples of algorithms
which successfully fullfill these criteria is the Gunn’s basis function method [39] and the
wavelet-aided parametric imaging approach (WAPI) [40].
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The latter of the two is used in study II and study V of this thesis. WAPI utilizes the
important feature of the wavelet transform, that spatial information of the signal is kept after
the transformation, whereas it is lost in the traditional fourier transform. More specifically,
the coefficients of a wavelet transform contain information about the frequencies of the
signal at a certain location (called "spatial frequencies"). This feature enables the wavelet
transform to separate the different components of the signal based on their frequency. The
noise component of the signal is represented by high frequencies, whereas the real (noise-
free) signal, consists of lower frequencies. Consequently, the noise component of the signal
can be identified and discarded.
The transformation into wavelet coefficients is realized in an iterative process sep-
arating the high from the low spatial frequencies using wavelet filters with finite support.
The high frequency component is retained, while the low frequency component is separated
at the next iteration into high and low frequencies. The most suitable length of the wavelet
filter (filter kernel length, fkl ), as well as the optimal number of iterations (decomposition
depth, dd ) may depend upon the PET image resolution and the reconstruction procedure,
and should thus be optimized for each PET system (see further section 3.7).
WAPI uses the Logan Graphical Analysis approach (equations 8 and 14). Since the
wavelet transform is a linear operation that is applied on each frame separately, the temporal
dynamics of the tracer are unchanged in the transformation. This enables the linear fitting
of equation 8 and 14 to be performed on the wavelet coefficients rather than on radioactivity
values of the voxels. The coefficients displaying low values are discarded from the fits, and
the remaining slopes are converted back into image space. The resulting image will thus
display the distribution of VT or DVR, depending on whether the invasive (equation 8) or
non-invasive (equation 14) method was used.
1.4 PET methodology advancements
1.4.1 High resolution research tomograph (HRRT)
The High Resolution Research Tomograph (HRRT), a state-of-the-art system for human
brain PET imaging, was installed at Karolinska Institutet in 2007 and was operational from
2008. The transition from the fourth generation PET systems, such as the ECAT EXACT
HR to the HRRT, introduced an improvement in resolution, from ∼ 4 mm FWHM in the
HR to∼ 2 mm in the HRRT. This improvement was a result of several new features in both
hardware and software.
First, the gantry size of the HRRT is substantially smaller than that of the previous
generation system (35 cm vs 56 cm in gantry diameter [41, 42]). The smaller gantry size re-
duces measurement errors caused by the non-collinearity effect and photon scattering (see
section 1.3.4). Second, the HRRT contains substantially more and smaller crystals than its
predecessor. The detectors of the HRRT are organized in an octagonal array of detector
heads. Each head consists of 9× 13 detector blocks, each with an 8× 8 array of detectors.
Third, each detector consists of 2 layers of scintillating crystals: Lutetium oxyorthosilicate
(LSO) in the innermost layer, and lutetium-yttrium oxyorthosilicate (LYSO) in the outer-
most layer. The double layer geometry enables the measurement of depth of the photon
interaction within the crystal and thereby reduces the parallax effect [43]. The HRRT uses
119808 detectors in total, each with a volume of 2.15× 2.15× 10 mm3 and with a 2.4 mm
center-to-center distance between crystals.
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Fourth, the HRRT acquires data in list mode, meaning that each coincident and single
count is recorded in a long list. This representation of the recorded data provides more flex-
ibility when reconstructing the images, as the definition of time frames can be determined
post acquisition. The standard procedure for reconstructing HRRT data at Karolinska In-
stitutet is 3D-OP-OSEM, including modeling of the system PSF. The implemented PSF
model is described in detail by Comtat et. al. [44], and differs from the original imple-
mentation described by Sureau et al. [45] with regards to the projectors used (see section
1.3.3). In the model, the PSF is approximated by a superposition of two isotropic 3D Gaus-
sian functions, with FWHM1 of 2.1 mm and FWHM2 of 5.9 mm, and Gauss1 to Gauss2
ratio of 0.01 [19]. With regards to the number of iterations needed before convergence
of the OSEM, Varrone et al. showed that only marginal improvement in resolution was
achieved when the number of iterations was increased above 10, whereas the noise level
significantly increased [19]. Therefore, the standard number of iterations was set to 10.
Taken together, the final resolution of the HRRT at the Karolinska Institutet was found to
be 1.5 mm FWHM in the center of the field of view, and 2.4 mm at 10 cm distance from
the center.
1.4.2 Partial volume effect correction
The term partial volume effect (PVE) for medical imaging originally referred to the signal
artifacts originating from the relatively large voxel sizes of the images. The volumes of
the voxels of early generation PET and MR systems were so large that they could contain
a significant proportion of two or more tissue types. The volume constituting the voxel
was therefore said to consist of two or more partial volumes, which affected the reliability
of the values of individual voxels, particularly for voxels close to tissue boundaries. With
the development of higher resolution imaging systems, the voxel sizes has decreased, and
modern system are associated with voxel volumes of ∼ 1 mm3. Consequently, the original
definition of PVE is today not a major issue.
For emission tomography modalities however, there exists also another type of signal
artifact, which is also called PVE. The limited resolution of these modalities causes the
radioactivity to spill over between structures. The effect becomes particularly pronounced
for brain structures which are associated with a high density of binding sites, and are sur-
rounded by low density structures. Depending on the resolution of the system, the extent
of radioactivity spilled out may cause the measured radioligand binding in such structures
to be significantly underestimated.
Figure 7 illustrates how in the (1D) PET image, the signal measured from each of
the structures is contaminated by the signal from the neighboring structures. Moreover,
the maximal radioactivity estimated in each structure is reduced, which is particularly pro-
nounced in the high density region (x3 ≤ x ≤ x4). In a PET image, all neighboring
regions are thus contaminated by each other. By assuming that the resolution of the system
is known, and that the boundaries between contaminating structures can be defined, this
aspect of PVE can be corrected. In this thesis, three different methods for PVE corrections
are used. Two are so called voxel-based methods, meaning that they produce a new, PVE
corrected image. The third method is ROI-based, and thus affects the TACs rather than the
actual PET image. All methods assume that for each measured PET image IPET , there
exists a true image I true, which, when convolved with the system PSF (here denoted h to
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Figure 7. Illustration of the partial volume effect for PET images. The signal obtained from neighboring
structures with different density of receptors is contaminated. The higher the resolution of the system, the
less the extent of PVE. If the resolution of the system and the spatial location of the regions (the coordinate
xi in this figure) is known, the images can be corrected for PVE.
be consistent with previous publications), are equal
IPET = I true ⊗ h. (15)
Thus, correcting for PVE is a deconvolution problem.
Meltzer’s method The method proposed by Meltzer et al. [46] assumes homogeneous
binding in brain tissue and no binding in cerebrospinal fluid (CSF). The only border which
needs to be PVE-corrected is that between brain tissue and the CSF present in the ventricles
and outside the brain. To define that border, segmented and coregistered MR images can
be used. To estimate the amount of signal loss, an image mask is created, such that it
contains 1s in voxels corresponding to brain tissue, and 0s everywhere else (Itissue). This
mask is subsequently artificially degraded to the resolution of the PET, by convolution with
the system PSF (IMask ⊗ h). Given the resolution of the system, the degraded mask holds
information regarding how much signal has spilled out from each voxel. Thus, the PET
image corrected with Meltzer’s approach is retrieved via
I true =
IPET
Itissue ⊗ h. (16)
Müller-Gärtner’s method Müller-Gärtner’s approach (MG) [47] assumes that radioli-
ogand binding in gray matter (GM) is homogenous, binding in white matter (WM) is ho-
mogenous, and that binding in CSF is non-existent. The MG method is designed to improve
quantification of radioligand binding only in GM, and thus aims at correcting the border
between GM and WM, and between GM and CSF. The border between GM and CSF can
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easily be corrected for in a manner similar to that used in Meltzer’s approach. To correct
the border between GM and WM, however, the MG approach assumes that the value in
every WM voxel can be replaced by the average WM signal, which can be obtained from
an uncontaminated part of the middle of the WM, typically the centrum semiovale.
If kWM denotes the average signal in WM, and IGM and IWM denote masks for GM
and WM, respectively, then the amount of contamination from WM in the signal measured
from GM can be estimated by kWM{IWM ⊗ h}IGM . This quantity needs to be subtracted
from the original PET image. Similar to Meltzer’s approach, the degradation of the GM
mask to the resolution of the PET provides information regarding the loss of signal in each
GM voxel. The final equation describing the correction procedure for the MG approach
becomes
I true =
IPET − kWM{IWM ⊗ h}IGM
IGM ⊗ h . (17)
Figure 8. Summation PET image of [11C]MADAM acquired with the HR system, before and after correction
for Partial Volume Effects.
Rousset’s method The method described Rousset et al. [48] differs from the previous
methods in that it does not create a PVE-corrected PET image. Instead it operates only
on the values measured in each of the ROIs. The method assumes that the radioactivity
value measured in ROI i (xi), is a weighted combination of the true value in ROI i (yi),
and the true value in all other ROIs. The weights aij determine the impact of ROI j on the
measurement of ROI i. More specifically,
x1 = a11y1 + a12y2 + · · ·+ a1nyn
...
xn = an1y1 + an2y2 + · · ·+ annyn
(18)
or in matrix form
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 x1...
xn

︸ ︷︷ ︸
x
=
a11 · · · a1n... . . . ...
an1 · · · ann

︸ ︷︷ ︸
A
×
 y1...
yn

︸ ︷︷ ︸
y
. (19)
The weights, i.e., the elements of A, are determined by calculating the amount of cross
contamination between each of the ROI pairs. An estimate of the cross contamination can
be obtained by smoothing a mask of the ROI i with the PSF, and calculating the amount
that the ROI contaminates all other ROIs [49].
Once all the elements of A are known, the true radioactivity values are obtained by
y = A−1x. (20)
In some publications, this method is referred to as the geometric transfer matrix (GTM)
method, where the geometric transfer matrix is the matrix A above [50, 51].
Drawbacks The main drawback of the above-mentioned methods is that assumptions
need to be formulated a priori regarding the borders along which PVE occurs. For the
Meltzer and the Müller-Gärtner methods, these borders are defined from segmented MRI
and are therefore dependent on accurate coregistration of the MRI. In addition, the Meltzer
approach only corrects spill-over of radioactivity between brain tissue and CSF, and there-
fore, the effect of applying the method may not be very well pronounced, particularly for
sub-cortical regions. The MG approach has some limitations in terms of reliability because
it may sometimes overcorrect the data [52]. This overcorrection is often visible in the
PVE-corrected images; in thin cortical regions embedded between CSF and WM, individ-
ual voxels can gain over 100% of the measured value in the PVE correction step, making
the data less reliable (see figure 8). For the method described by Rousset, the main limita-
tion is that each voxel in the PET image must be assigned to exactly one ROI to be correct.
Voxels which are not assigned to an ROI may contaminate other ROIs, but the contamina-
tion will not be corrected for when applying equation 20. This limitation introduces the
need for using ROI templates to make the method practically feasible.
Other methods There have been suggested methods that remove the limitations de-
scribed above. The convolution problem described in equation 15 can be addressed using
deconvolution techniques. For instance, Teo et al [53] and Tohka and Reilac [54] ap-
plied the Van Citter deconvolution algorithm. The Van Citter deconvolution is an iterative
scheme, with the goal of estimating the true PET image I true so that the blurred image
I true ⊗ h matches the measured image IPET . The basic idea is to minimize the function
(IPET −I true⊗h)2, by finding the I true for which the derivative of the function becomes 0.
Apart from the original publication by Tohka and Reilhac, only a few publications use the
the Van Citter deconvolution scheme [55]; overall, the algorithm has not been frequently
utilized.
Another sophisticated approach was proposed by Bouisson et al., which, by wavelet
transforming high resolution images such as MR or CT images, transfers the high frequency
information (such as edges and details) into the PET images [56, 57]. A potential drawback
of such a procedure is that it will introduce image artifacts when there are slight errors in
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the co-registration. The method has also been criticized for not being based on a solid
theoretical foundation [58].
1.4.3 Imaging the serotonin transporters in the brainstem
The serotonin neurotransmission system is widely distributed in the brain. It is involved in
numerous physiological functions, including mood and social interaction [59], cognition
[60], thermoregulation [61], sleep [62], and pain [63]. Serotonin originate from the raphe
nuclei in the brainstem, from where it is projected to essentially all cortical regions. The
raphe nuclei are of moderate-size, and distributed along the midline of the brainstem in the
rostro-caudal extension. The rostral structures (i.e., the caudal linear, the dorsal raphe, and
the median raphe nucleus) project primarily to the forebrain, whereas the more caudal com-
plex (raphe magnus, raphe obscurus, and raphe pallidus) project to the brainstem itself and
to the spinal cord [64, 65]. Abnormal serotonergic transmission from the raphe nuclei has
been implicated in several psychiatric and neurological conditions, including Alzheimer’s
disease [66], Parkinson’s disease [67], depression [68], and suicidal tendencies [69]. In
addition, loss of serotonergic neurons in the median and the caudal raphe nuclei has been
observed in patients with Parkinson’s disease [70]. Thus detailed mapping of serotonergic
transmission in the raphe is necessary for several areas of neuroscience.
Accurate in vivo imaging of the raphe nuclei using PET has the potential to elucidate
the role of the serotonin system in neurological disorders. However, the limited spatial
resolution of PET has traditionally prevented accurate quantification of radioligand binding
in small brain structures, such as the raphe nuclei. As described in section 1.4.2, the small
volume of the raphe in combination with a low resolution system lead to significant spill-
out of radioactivity, making changes in receptor or transporter densities difficult to detect.
Moreover, since the raphe nuclei are not easily visible on MR images, they cannot be
accurately delineated. Consequently, the PVE-correction techniques discussed in 1.4.2
cannot be applied. The only possible solution for accurate measurement of receptor or
transporter availability in the raphe is a high system resolution.
In theory, the resolution of the HRRT is high enough to resolve the nuclei of the raphe.
However, Leroy et al. reported that the voxel-to-voxel noise level of the HRRT is too high
for reliable quantification of small brainstem regions using conventional ROI-based kinetic
modeling [71]. In that paper, the authors concluded that parametric imaging, and noise
suppression techniques are necessary for reliable quantification in small brainstem regions.
The serotonin transporter (5-HTT) has frequently been used as a marker for sero-
tonergic neurotransmission. The radioligand [11C]MADAM [72] binds selectively to the
5-HTT and is therefore suitable for measuring 5-HTT in the raphe. In addition, the wavelet
aided parametric imaging approach (WAPI) for generation of parametric images [40] suc-
cessfully reduces the noise level in PET data, while maintaining reasonable resolution [73].
Hence high resolution PET imaging using HRRT together with WAPI may be suitable for
quantification of radioligand binding in small structures of the brainstem. In study II, this
procedure is undertaken, in combination with an in-house developed semi-automatic pro-
cedure for delineation of small ROIs, in order to examine the possibility of quantifying
5-HTT density in the raphe nuclei.
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1.4.4 Automatization of ROI delineation
The number of applications of PET in neuroscience research has steadily increased over
the last decade. The unique capability of PET to study functional processes in the living
human brain has provided useful insights into many fields of neuroscience including psy-
chiatric and neurodegenerative disorders, as well as cognitive neuroscience [12, 14, 74].
The increased use of PET in neuroscience research has lead to the acquisition and accu-
mulation of a substantial amount of PET data, acquired by different researchers and for
different scientific purposes. Nevertheless, if analyzed in a stream-lined fashion, the PET
data currently available can be combined into datasets from which novel research questions
can be addressed.
As described in section 1.3.5, the definition of regions of interests (ROI) is a required
step in conventional PET data analysis. Traditionally, ROIs are manually delineated, mean-
ing that a neuroanatomically trained expert draws the ROIs by hand upon MR images. This
procedure introduces a large amount of user interaction in the data analysis, making it
prone to rater bias. The procedure may thus show low reproducibility. In addition, manual
definition of ROIs is time consuming and prevents swift analysis of data. These limitations
become particularly challenging when the dataset at hand is large and pooling of data from
a large number of subjects is necessary. In order to generate databases of PET data accu-
mulated over the years, we must bypass the manual ROI delineation step in the analysis
workflow.
Automatic methods to define the ROIs would overcome these limitations. During
the last decade, several software packages have been developed, which are based upon
MRI templates and provide a set of automatically generated ROIs. Although such software
would be of general benefit for PET research, applications of automated methods for ROI
delineation are still limited in the literature. One possible explanation is that since the
definition of ROIs is a crucial step in the analysis, automated methods need to be thoroughly
evaluated before they can be applied routinely.
In study III of this thesis, two such automated methods for ROI delineation are eval-
uated. The methods are the Automatic Anatomic Labeling (AAL) template [75] and the
FreeSurfer package [76]. The AAL is based on an existing template of pre-defined ROIs.
The template is stored in the general MNI space [77], and when applied to a subject, the
template is warped to the space of the individual MRI. AAL is easily accessible in the
Statistical Parametric Mapping (SPM) toolbox for MATLAB. The FreeSurfer package is a
more sophisticated software package, that was originally developed for cortical reconstruc-
tion, volumetric analysis, and segmentation of structural MR images. The whole FreeSurfer
package is freely available online (http://surfer.nmr.mgh.harvard.edu/), and the technical
details can be found in the following references [78–97].
Both AAL and FreeSurfer are associated with benefits and potential drawbacks. AAL
is fast and easy to use, and thereby provides means to quickly derive TACs from a large
number of subjects. A potential limitation is, however, that the normalization of the tem-
plate might not be accurate for individuals whose brain structures deviate substantially
from the template, for instance patients with severe atrophy or other structural changes. In
contrast, the FreeSurfer registration, which is based upon the individual cortical folding
patterns rather than image intensities, may provide increased stability for subjects with se-
vere atrophy. However, FreeSurfer is associated with a substantially higher computational
load than the AAL, requiring up to 20 hours of processing time per subject [98, 99].
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The aim of study III was therefore to validate and compare the performance of the
two automated methods for routine analysis of PET data.
1.4.5 Image-derived input functions
As described in section 1.3.6, in absence of a suitable reference region, the radioligand
concentration in arterial plasma needs to be known for full quantification of PET data. The
concentration of the unchanged radioligand in arterial plasma is used as the input function
for the kinetic models described in section 1.3.6. This arterial input function is normally
acquired by measuring the radioactivity level in blood samples obtained from an arterial
catheter. This procedure is associated with several limitations. Arterial cannulation is a
laborious procedure for the research personnel, and often found uncomfortable, or even
painful, for the patients. Moreover, to capture the kinetics of the initial bolus of radioactiv-
ity, the arterial sampling needs to be performed at such high frequency that special blood
sampling equipment is required. Arterial sampling is also sensitive to errors and intro-
duces an increased risk for adverse events. A non-invasive procedure to estimate the input
function would be preferable.
A suggested solution has been to estimate the input function directly from the PET
image, and two different categories of approaches have been proposed. The first strategy
is to combine (manual or automatic) delineation of ROIs for the arteries with tools that
compensate for signal artifacts, and the second strategy is to "un-mix" the mixed signals of
the PET image.
Methods for applying the first strategy have been developed by a large number of
researchers for various radioligands [100–107]. The most straight-forward procedure in
order to segment the carotid artery is to use a coregistered MRI from which the carotid
artery can be easily segmented [101, 104]. From the MR image, information regarding
the length and width of the carotid can be accurately determined, which can be used to
compensate for signal loss. However, most coregistration techniques don’t provide reliable
alignment of the vessels, because 1) most of the existing coregistration algorithms assume
that the MR and PET images can be aligned using rigid body transforms (which may be
true for the brain itself but not for the neck region due to different positioning of the patient
in MR and PET acquisitions), and 2) the calculations are performed using structures above
the carotids. Fung et al. even found that the individual carotids needed to be coregistered
separately in order for their MR-based method to work [104].
Another possibility is to define the ROI directly on the PET image itself, which has
the benefit that no coregistration to MR images is needed. The obvious drawback is that
the carotid artery is not easily detectable in a dynamic PET image. Chen et al. suggested to
use a summation image of the early time frames, during which the injected bolus of activity
was still in the vessels [108]. In this time window, the vessels are clearly visible, enabling
manual delineation of the carotid artery ROI directly on the PET image. In the original
publication by Chen et al., ROIs covering the vicinity of the artery were also manually
delineated in order to estimate and correct for signal contamination.
The procedure to only use the early time frames for obtaining the carotid artery ROI
was later adopted by several researchers, which replaced the manual delineation step with
automatic alternatives. First, Chen et al. applied independent component analysis (ICA)
on the summation image in order to obtain the artery ROI [109]. Later, Mourik et al.
proposed to define the ROI on the summation image of early frames, as the 4 hottest voxels
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in each plane, ranging from the level of the Circle of Willis to approximately 10 cm down.
[110]. Hahn et al. developed a sophisticated approach feeding the early frames into a linear
discriminant analysis algorithm together with a set of tissue classes, including vascular
tissue. The procedure enabled identification of the voxels resembling blood properties in
the early part of the acquisition [107].
One problem of the above methods is that they only consider the radioactivity values
in the beginning of the measurement. Thus, voxels which have high values in early frames
are included in the ROI, regardless of the shape of the TAC during the remainder of the
measurement. All voxels that experience noisy TACs in later time frames will be kept,
which may introduce an unnecessary amount of noise in the blood TAC. This problem
becomes particularly challenging for HRRT data, in which the voxel-to-voxel noise level
is considerably high. In an ideal algorithm, the whole blood TAC should be considered,
so that the final ROI only includes voxels displaying blood-like behavior during the whole
measurement. One such application was developed by Liptrot et al. [111]. In that article,
the authors applied K-means clustering [112] on a set of PET images of [18F]altanserin.
In K-means clustering, each cluster center (i.e., the "true" TAC) is defined as the mean of
the cluster members (i.e., the TACs assigned to the cluster). The final solution is reached
after iterating through a loop that reassigns the voxels and updates the centers. After the
algorithm is stabilized, the cluster centers correspond to the final tissue TACs.
The second strategy to estimate the blood signal is to "un-mix" the assumed mixed
signals in the PET image. More specifically, the TAC of each voxel can be considered to
be a linear combination of a set of underlying "true" TACs. Thus, by applying unmixing
algorithms, the true TACs, of which the blood TAC is one, can be identified. Approaches
belonging to this category are for example those by Naganawa et al. [113], and Bodvarsson
et al. [114]. Naganawa et al. used a set of [18F]FDG images, on which ICA was applied to
identify the underlying two independent components, which were assumed to be "tissue"
and "blood". A similar approach was implemented by Bodvarsson et al. where the signal
separation of the voxel TACs was performed with matrix factorization with non-negativity
constraints. For both Naganawa’s and Bodvarsson’s approaches, the shape of the signal is
maintained, whereas information regarding the amplitude is lost.
Although signal separation techniques seem like an attractive option, the number of
publications utilizing similar methods is limited, possibly due to their level of complexity.
Since the clustering is based on the kinetic properties of the tracer, it is likely that the algo-
rithm needs to be tuned for each radioligand. Also, noise properties and system resolution
are likely to affect the behavior of such an algorithm, and thus, differences in performance
between different PET systems and reconstruction methods are expected.
Despite the efforts undertaken during the last decade, applied PET studies utiliz-
ing image-derived input functions (IDIFs) are rare. Due to the low resolution and high
noise levels associated with PET, several methods have shown low reproducibility when
implemented by other research groups [115], leading to a growing skepticism towards the
feasibility of the concept. In a recent review article, Zanotti-Fregonara et al. stated that
the difficulties associated with deriving an IDIF are too many and too difficult consider-
ing the potential benefit [116]. However, most attempts to derive blood curves have been
performed on PET data acquired on systems with significantly lower resolution compared
with the HRRT. The carotid artery is a small and elongated structure, with approximately 5
mm diameter [117], with complex hemodynamic patterns [118]. Thus system resolution is
likely a fundamental factor for accurate measurement of the IDIF.
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1.4.6 Amyloid imaging
Advancements in radioligand development have provided suitable imaging biomarkers for
studying brain physiology and disorders affecting the central nervous system (CNS). De-
velopment of radioligands binding specifically to amyloid-β plaques represent one of the
major advancements. Amyloid imaging using PET can quantify the distribution and den-
sity of amyloid plaques in the human brain. It has consequently proven to be a valu-
able tool for studying Alzheimer’s disease (AD), which is characterized by the deposi-
tion of amyloid plaques. Over the years, several new radioligands binding specifically to
amyloid-β plaques have been developed, for instance [18F]AZD4694 ([18F]NAV4694) and
[11C]AZD2184 [119, 120]. In addition to their specific binding to amyloid, these radioli-
gands have both shown low binding values in healthy subjects [121, 122].
AD is the most common form of dementia, accounting for a substantial proportion of
the total 35 million individuals estimated to suffer from dementia [123]. In 2010, the world-
wide cost associated with dementia was estimated to $604 million [124] and is predicted to
increase along with the prevalence of AD due to the increasing life expectancy. The cog-
nitive decline associated with the disease involves suffering for the affected individuals, as
well as for their close ones, and it motivates the large amount of research and resources
devoted to developing effective treatment strategies and diagnostic tools. To date, none of
the existing drugs have shown any long-term effect in the progression of the disease. One
possible explanation is that the conducted trials selected moderately affected individuals,
whose disease progression is difficult to revert [125]. The ability to identify individuals at
risk of developing AD at an earlier time point is thus a prerequisite for testing treatment
strategies [126] and may even facilitate early diagnosis of the disease.
Typically, the deposition of amyloid plaques appears years or even decades before
any cognitive symptoms are detected [126–129]. Amyloid imaging using PET may there-
fore serve as an early biomarker by enabling in vivo quantification of amyloid-β deposition
in brain. The first PET measurement of amyloid deposition was performed by Klunk et al.
in 2004 [130] and amyloid imaging has since then been widely applied in both research
and in clinical trials [131]. Recently, the FDA approved the clinical use of amyloid PET as
an aid to exclude the possibility of AD among individuals with established dementia [132].
Unfortunately, high levels of amyloid have been shown not to be specific for AD. In
addition to patients with a clinical diagnosis of AD, about 20-30% of healthy elderly indi-
viduals and about 50-60% of individuals with mild cognitive impairment (MCI) have been
shown to have non-negligible levels of amyloid-β [133–137]. Several studies have also
reported difficulties in separating controls subjects from AD patients with minor levels of
amyloid-β in the early course of the disease [138–140]. Thus the problem is multifaceted.
First, deposition of amyloid-β in the brain may be interpreted as a biomarker for AD, but
it does not necessarily exclude the possibility of the subject being healthy. Second, how do
we define a threshold for classifying subjects as amyloid positive or negative?
The second question has traditionally been addressed using ROI-based analysis, fol-
lowed by application of empirically defined thresholds. This method of differentiating
between amyloid positive and negative individuals has repeatedly been conducted with a
varying degree of success, often resulting in overlaps between the groups [137–139, 141].
A potential explanation is that the formation of amyloid-β plaques does not follow the
conventional boundaries defining the brain regions, making traditional ROI-based analysis
suboptimal. Thus, new, objective ways are needed for identification of important brain re-
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gions (or voxels) in which the differences between AD patients and controls are systematic
and as evident as possible.
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2 AIMS
The overall aim of this thesis was to validate established methods and to develop new
methodological tools for quantification and analysis of PET data. More specifically, the
aims were the following:
• To evaluate the effect of improved resolution on the measurement of 5-HTT avail-
ability.
• To evaluate and validate existing methods for correcting the partial volume effect.
• To develop a method enabling quantification of radioligand binding in small brain
structures.
• To evaluate and validate existing methods for automated delineation of regions of
interest for the analysis of PET data.
• To develop a method to obtain the image-derived arterial input function from dy-
namic PET data.
• To develop an objective method for classifying individuals as amyloid positive or
negative.
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3 MATERIALS AND METHODS
3.1 Rationale for selection of radioligands
Study I The purpose of study I was to compare the quantitative performance between
the HR and the HRRT PET systems. Previous comparisons have been conducted focusing
either on the cortical areas using the GABAA radioligand [11C]flumazenil [142] or on sub-
cortical areas using [11C]PE2I, a radioligand that binds to the dopamine transporter [71].
These radioligands provide high target-to-background ratio, but they are either concen-
trated to the sub-cortical regions (striatum and midbrain for [11C]PE2I) or more uniformly
distributed throughout the brain [11C]flumazenil). In study I, our interest was specifically
to assess the effect that improved resolution had on the quantification of radioligand bind-
ing in brain regions with different size and different receptor densities. The radioligand
[11C]MADAM [72] was used as it provides signal from cortical and sub-cortical brain
regions of different sizes and different serotonin transporter (5-HTT) densities.
Study II The purpose of study II was to develop a method for accurate quantification
of serotonin transporter availability in the small nuclei in the brainstem. The radioligand
[11C]MADAM was selected, since it binds selectively to the 5-HTT [72].
Study III The purpose of study III was to validate FreeSurfer and the AAL template
for automatic definition of ROIs in PET data analysis. Since the performance of the au-
tomated methods may vary across regions, the analysis would benefit from including a
large number of ROIs. Therefore, data acquired using radioligands for two targets having
different anatomical distribution were included in the study. First, the 5-HT1B receptor
radioligand [11C]AZ10419369 [143] was selected due to the wide distribution of 5-HT1B
receptors across brain regions [144, 145]. In addition, the presence of 5-HT1B receptors in
vascular tissue [146] may "contaminate" the regional TACs and thereby influence the per-
formance of the automated methods. Second, to evaluate whether brain atrophy affects the
performance of the automated methods, AD patients and control subjects measured with
the amyloid-β radioligand [11C]AZD2184 [147] were included in the study.
Study IV The purpose of study IV was to validate the use of image-derived input func-
tions as a substitute for arterial sampling. For this purpose, [11C]flumazenil was chosen
because its quantification often requires an input function; the suitability of pons as a ref-
erence region has been questioned [148]. In addition, [11C]AZ10419369 was included in
order to evaluate whether venous sampling can be used as a substitute to arterial sampling.
This is possible since the metabolism of [11C]AZ10419369 is negligible in humans. The
total radioactivity in plasma can therefore approximate the input function without the need
for metabolite correction.
Study V The purpose of study V was to identify the disease specific pattern of amy-
loid deposition among AD patients and to utilize that pattern in order to classify unknown
subjects. To avoid a bias in the evaluation, two different datasets were required; one for
determining the network (i.e., train the classifier) and one for testing it. To train the algo-
rithm, PET images obtained using the amyloid-β radioligand [18F]AZD4694 [120] were
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used. For testing purposes, PET images acquired using the radioligand [11C]AZD2184
[149] were used.
3.2 Research participants
This thesis to a large extent encompasses PET data acquired in different research projects.
All procedures were approved by the Ethics Committee of the Stockholm Region, and the
Radiation Safety Committee of the Karolinska University Hospital. All studies were per-
formed in accordance with the ethical principles that have their origin in the Declaration of
Helsinki and that are consistent with ICH/Good Clinical Practice. Written informed con-
sent were obtained from all subjects prior to initiation of the studies For details regarding
ages, injected radioactivities, specific radioactivities, and injected masses, please see the
corresponding article/manuscript in the appendix.
Study I and II Study I and II includes 6 male control subjects that were healthy according
to medical history, physical examination, ECG, and MRI. All subjects were examined twice
on the same day, once using the HRRT and once using the HR system. For each subject,
there was a 3.5 h interval between the measurements.
Study III Study III includes a total of 41 subjects, of which 20 were examined using the
HRRT and remaining 21 were examined using the HR PET system. Of the 41 subjects, 15
were examined using [11C]AZ10419369 and 26 were examined using [11C]AZD2184. Of
the subjects examined with [11C]AZD2184, 9 subjects were healthy according to medical
history, physical examination, blood and urine screening analyses, and MRI. The remaining
17 subjects were patients fulfilling the DSM-IV criteria for AD. The data used in study III
were acquired in 5 separate studies [121, 122, 149–151].
Study IV Study IV includes a total of 12 subjects, all of which were examined using the
HRRT. Of the 12 subjects, 6 were examined using [11C]flumazenil, and 6 were examined
using [11C]AZ10419369. All subjects were healthy according to psychiatric and medi-
cal history, physical examination, laboratory testing, ECG, and MRI. The [11C]flumazenil
dataset consisted of baseline measurements in an occupancy study which is not yet pub-
lished. The [11C]AZ10419369 dataset was acquired in an academic study [151].
Study V Study V includes PET data from a total of 26 subjects, all examined using the
HRRT. Sixteen subjects (10 AD patients and 6 controls) were examined using [18F]AZD4694
and 16 subjects (11 AD patients and 5 controls) were examined using [11C]AZD2184 (i.e.,
4 AD patients and 2 controls were examined with both radioligands). The data in study V
was acquired in two previously published studies [121, 122].
3.3 Data acquisition and reconstruction
All PET examinations included in this thesis were performed at the Karolinska Institutet
PET center, located at the Karolinska University Hospital, Solna, Sweden. An individual
plaster helmet was made for each subject to restrain the head and to prevent head motion
during the PET scan [152]. In all cases, the tracers were intravenously administered as
bolus injections after which the intravenous line was immediately flushed with saline.
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This thesis encompasses PET data acquired in the ECAT EXACT HR system and
the ECAT HRRT system (for scanner description of the HRRT, see section 1.4.1). All HR
data were reconstructed using filtered back projection with a Hann filter of 2 mm cut-off
frequency. All HRRT data were reconstructed using 3D ordinary poisson ordered subset
expectation maximization, with PSF modeling, and 10 subsets and 16 iterations (see further
section 1.3.3). For studies I, II, and IV, radioactivity levels in arterial blood were measured
via an automatic blood sampling system (ABSS, Alogg Technology, Mariefred, Sweden)
for the first five minutes, followed by manual arterial sampling at the midpoint of each
time frame. Input functions were obtained by correcting the measured radioactivity level
in arterial blood with the plasma fraction (i.e., plasma-to-blood ratio), and with the non-
metabolized (parent) fraction.
Each study utilizes coregistered T1-weighted MR images. For all studies, MR images
were acquired on a 1.5 T GE signa system (GE medical systems, Milwaukee, WI, USA).
In addition, for a few of the subjects included in study III and V, MR images were acquired
using a 1.5 T Siemens Avanto system (Siemens Medical Systems, Erlangen, Germany), and
one of the subjects included in study 4 was imaged using a 1.5 T Gyroscan Intera system
(Philips Medical Systems, Best, The Netherlands). All MR images were coregistered to
the PET image and segmented into gray matter, white matter, and cerebrospinal fluid, using
Statistical Parametric Mapping 5 (SPM5, Wellcome Department of Cognitive Neurology,
University College, London, UK).
3.4 Definition of regions of interest
Manual ROIs were used in studies I, III-IV, and were delineated using the in-house soft-
ware Human Brain Atlas [153]. In study II, the included ROIs were delineated using a
semi-automatic algorithm, which is explained in detail in section 3.7.2. In study III, both
manually defined ROIs, and automated ROIs obtained with AAL and FreeSurfer were used
(see further section 1.4.4). Study V included two manually defined ROIs which were man-
ually delineated using Human Brain Atlas in order to generate the clusters (cerebellum
as a reference region for WAPI, and posterior cingulate cortex as a seeding region to the
PWC method). The clusters obtained from the PWC method were also used as ROIs for
separation between AD patients and control subjects.
3.5 Partial volume effect correction
Correction for partial volume effects were applied in studies I and IV. In study I, the purpose
was to compensate for the effect of disparate resolutions on the outcome measures obtained
from the HR and the HRRT systems. Therefore, both HR and HRRT data were corrected
using the PVE correction techniques described by Meltzer et al [46], and Müller-Gärtner et
al. [47]. Both methods are described in detail in section 1.4.2.
In study IV, the signal obtained from the carotid artery ROIs was corrected for PVE
using a modified version of the geometric transfer matrix (GTM) approach proposed by
Rousset et al. [48]. The modification was introduced because the amount of spill-out of
radioactivity from the carotid ROI varies throughout the PET measurement. In the initial
phase when the radioactivity is still in the vessels, the spill-out is a major issue. At later
time points, the radioactivity gradient between the vessels and their vicinity is smaller and
could potentially be neglected. Therefore, only the first 3 minutes of the acquisition were
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corrected for partial volume effects using the GTM method reduced to one compartment
(i.e., only correcting for spill-out from the ROI), and a 2 × 2 × 2 mm FWHM Gaussian
filter. The width of the filter was set slightly higher than the measured system resolution,
since the carotid artery is not in the center of the field of view.
3.6 Kinetic and graphical analysis
Several different outcome measures and models are used in this thesis. Each of the used
models are explained in section 1.3.6. In study I and III, regional BPND is calculated
using the SRTM. In study IV, regional VT is calculated using the Logan Graphical Analysis
approach. In studies II and V, the quantification is based upon parametric images of BPND,
which are calculated using the non-invasive Logan Graphical Analysis approach and the
cerebellum as a reference region (see section 1.3.7). Lastly, for the [11C]AZD2184 data
included in study III, regionalDVR is estimated by dividing the area under the curve (AUC)
of the target TAC to that of the reference region TAC over a specific time interval (in
this case, 15-45 minutes post injection). This method has previously been described as a
suitable approach for quantification of [11C]AZD2184 data [149].
3.7 Parametric imaging
Studies II and V were quantified using parametric images obtained with WAPI. As de-
scribed in section 1.3.7 and 1.4.3, the performance of WAPI depends upon the length of
the wavelet filter (filter kernel length, fkl ) as well as upon the number of iterations (decom-
position depth, dd ). Cselényi et al. have previously concluded that for HR data, an fkl of
22 together with a dd of 2 provided the highest possible recovery of regional BPND [40].
However, the optimal parameter settings for WAPI depend upon the system resolution, as
well as the noise properties in the images, and thus need to be optimized for each system. In
order to identify the most suitable parameter combination for HRRT images, the procedure
described below in section 3.7.1 was undertaken.
3.7.1 Optimization of wavelet-aided parametric imaging for HRRT
In a systematic approach to identify fkl and dd for the HRRT data, parametric images were
generated for numerous parameter combinations, when 14 ≤ fkl ≤ 40 and 2 ≤ dd ≤ 6.
Regional BPND was estimated from each image using one large ROI, consisting of the
frontal and temporal cortex, and in one small ROI, consisting of the dorsal brainstem. Both
ROIs were manually delineated on the MR image. For the same regions, regional BPND
was also estimated using conventional ROI-based graphical analysis with non-invasive Lo-
gan plot, and the percent difference in BPND estimated with the two methods was calcu-
lated. The combination of parameters that provided the best overall agreement with the
ROI-based graphical analysis was selected for further analysis.
3.7.2 Delineation of small brain structures
As described in section 1.4.3, accurate quantification 5-HTT density in the raphe nuclei is
of great importance for the study of the serotonin system in physiological and pathological
conditions, but PET imaging of such small structures has traditionally been obstructed
by the limited resolution of PET. Although the resolution of the HRRT is high enough
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to properly resolve the different nuclei of the raphe, it has previously been shown that
conventional analysis of regional TACs is not suitable for small ROIs due to the high voxel-
to-voxel noise level of the HRRT [71]. A suitable alternative is to use parametric imaging
in combination with noise suppression techniques.
To estimate the BPND of [11C]MADAM in the raphe, an ROI delineation procedure
for accurate definition of very small ROIs was developed. The procedure requires a para-
metric image and a coregistered MRI, and is as follows:
1. Using both the parametric image and the coregistered MRI, the top and bottom slice
of the structure of interest is identified.
2. On each of those two slices, a rectangle is drawn covering the structure.
3. A bounding box is defined as the volume between the two rectangles, and is retrieved
via linear interpolation over all intermediate planes.
4. The bounding box is eroded, so that all voxels with a BPND value lower than a
predefined threshold are excluded from the ROI. The threshold is defined so that the
volume of the final ROI coincides with the known volume of the structure.
5. Finally, the eroded ROI is applied to the parametric PET image.
The ROI delineation procedure is shown in figure 9. Since the method is based upon
applying a threshold, one obvious drawback is that the method requires a rather high signal
from the structure to be delineated. ROIs for structures associated with a low signal are at
risk of being scattered (non-continuous) and thereby, might not reflect radioligand binding
in a clearly defined area.
3.8 The pairwise correlation (PWC) approach
The pairwise correlation (PWC) method is used for two different purposes in study IV and
study V. In Study IV, the PWC method is used to identify all voxels displaying blood-like
behavior in order to estimate the image-derived input function. In study V the same method
is used in order to localize the disease specific pattern of amyloid deposition, which char-
acterizes Alzheimer’s disease. The PWC method is an adoption of an algorithm originally
developed by Benjaminsson et al. for the analysis of resting-state fMRI data [154]. Several
modifications were introduced in order for the algorithm to be applicable to PET images.
Initially, the algorithm by Dr Benjaminsson calculated the mutual information between
each voxel pair in the image. Mutual information however requires quantization of voxel
values, which is not an appropriate strategy for PET imaging. Several different measures
were evaluated, and the Pearson correlation coefficient was determined to be the most suit-
able statistical measure. In addition, the original algorithm includes a second step, where
multidimensional scaling was applied in order to detect patterns in the data. Although that
method provided very good results for fMRI images, it has not yet been shown to work
well for PET.
3.8.1 The general PWC method
The PWC method is characterized by the calculation of the correlation matrixM, such that
element i, j of M contains the Pearson Correlation Coefficient between the TACs xi and
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Figure 9. ROI delineation procedure for the raphe nuclei. Step 1, On coregistered MR images, top and
bottom slices for each ROI were selected. Subsequently, a rectangle was drawn on the two slices such
that the anatomical structure was well encapsulated within the intermediate volume between the top and the
bottom rectangles. Step 2, The bounding box was eroded. Only those voxels for which the BPND value in
the parametric image was higher than a predefined threshold (red line) constituted the final ROI. Step 3, The
eroded ROIs were applied to the parametric PET images.
xj of voxel i and voxel j,
Mi,j =
∑T
t=1(xi(t)− x¯i)(xj(t)− x¯j)√∑T
t=1(xi(t)− x¯i)2
√∑T
t=1(xj(t)− x¯j)2
, (21)
where T denotes the number of time frames of the PET image.
The i:th row of M contains the correlation coefficients between voxel i and all other
voxels in the image. Therefore, by selecting the rows corresponding to a few interesting
voxels, all voxels correlating with the interesting voxels are identified. To limit the size of
M, only those entries for which the corresponding voxel pairs displayed a strong measure
of correlation (|Mi,j| ≥ θ with 0 ≤ θ ≤ 1) were kept. In addition, to avoid extracting
noisy voxels, all autocorrelations were manually zeroed (i.e., Mi,i = 0). This modification
allows M to be represented as a sparse matrix, which is highly beneficial considering the
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large number of voxels in the images. Once M is calculated, the selection of which rows
to extract differs between the two applications.
3.8.2 PWC approach for image-derived input functions
PET images from the HRRT contain ∼ 14, 000, 000 voxels. The number of elements in M
is therefore ∼ 14, 000, 0002, which is a problematic matrix size even for a supercomputer
to handle. For this application, an image subset was defined to reduce the computational
load, containing only the neck region of the image (see figure 10). To identify all vox-
Figure 10. 3D-rendered summation PET image of one subject measured with [11C]flumazenil. Gray box
indicates the image subset used in the PWC algorithm to obtain image-derived input functions.
els within the subset displaying blood-like behavior, coregistered MR images were used.
Since the signal from the carotid artery in MR images is very strong, the vessels can easily
be segmented. At least a few of the carotid artery voxels identified from the segmented
MRI are likely to display-blood like behavior, whereas others may display primarily noise.
The noisy voxels will not correlate much with other voxels and therefore, will not affect
the result. In contrast, the voxels with blood-like shape will correlate with all other voxels
displaying blood-like behavior, which are identified as the entries in the rows of M cor-
responding to the artery voxels, with elements larger than 0. To identify all voxels with
blood-like behavior, the rows of M corresponding to the voxels obtained from the seg-
mented MRI were extracted and averaged into a single vector, where the i:th component
contains the average correlation between voxel i, and all carotid artery voxels (as defined
by the segmented MRI). The final carotid artery ROI was defined as all elements > 0 in that
vector. The procedure described above is also illustrated in figure 11.
The carotid artery is a small, elongated structure with a diameter of approximately 5
mm [117]. The signal obtained from the cluster can therefore be assumed to be affected
by substantial spill-out of radioactivity. The amount of spill-out from the ROI depends
upon the radioactivity gradient between the vessel and the surrounding tissue, and thereby
changes over the course of the measurement. A typical blood TAC consists of an early
peak of radioactivity (approximately for 0 ≤ t ≤ 3 minutes), followed by a long tail during
which the radioactivity concentration in arterial blood is low and relatively unchanging.
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Figure 11. a Pearson product-moment correlation coefficient (PCC) between all voxel pairs in an image
subset (number of voxels N ∼ 106) stored in a sparse matrix M. The PCC between the time-activity
curves of voxels i and j is highlighted. b Carotid artery voxels were segmented from coregistered magnetic
resonance (MR) images and used as indices to rows ofM to extract correlated (columnar) voxels.
During the initial phase, when the bolus of radioactivity is still in the vessels, the gradient
is large and substantial spill-out is expected. At later time points however, the gradient is
much smaller and can potentially be neglected. Therefore, in this application, the first three
minutes of the blood signal derived from the ROIs obtained from the PWC method were
corrected for spill-out using a modified version the GTM method [48], The modification
consist of reducing the number of compartments (or ROIs) to one. The TAC is thereby
only corrected for spill-out of radioactivity, and contamination from the surrounding tissue
to the vessel is neglected. The remaining part of the blood curve (the tail, t > 3 minutes)
was scaled to the manually obtained blood samples.
3.8.3 PWC approach for amyloid clustering
In the general PWC approach described in section 3.8.1, regions or voxels can be used
as seeds by extracting the rows of M that correspond to those voxels or regions. For
estimation of image-derived input functions, the seeding region was defined as the carotid
artery voxels obtained from segmented MR images. Similar approaches can of course be
used in order to identify other types of networks of radioligand binding.
One potential application is to use the PWC approach to identify patterns of amy-
loid deposits. Although the deposition of amyloid plaques is widely distributed throughout
the brain, the pattern of regional distribution may vary considerably across individuals. It
has been shown that the pattern of regional distribution of amyloid-β affects the extent
of cognitive decline, particularly if the pattern includes brain regions involved in memory
encoding and decoding [155, 156]. If a pathological pattern of amyloid deposition charac-
terizing the disease can be identified, it can facilitate differential diagnosis of AD. Below
is a description of how the PWC approach was used to identify the pattern, and how the
clusters were used to objectively discriminate between AD patients and controls subjects.
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Identification of the patterns To test whether the above hypothesis was true, PET mea-
surements from a total of 32 individuals (21 AD patients and 11 control subjects) were
included. Rather than applying the PWC method on dynamic (4D) PET data, individual
parametric images of BPND were used [40]. All individual (3D) parametric images were
normalized to a common space (MNI) using SPM and stacked after each other along the
fourth dimension, similar to what has been done for the serotonin and opioid systems [157].
In this way, each voxel displays a curve (or voxel curve) describing the interindividual vari-
ability of BPND. All pairwise correlations were then calculated between these voxel curves
and stored in a sparse correlation matrix M. Two different approaches for identifying the
disease specific pattern were evaluated.
Clustering using a priori assumption Firstly, similar to what was done for the case of
the image-derived input function, a seeding region was used to determine which rows in
M to extract. The posterior cingulate cortex (PCC) has repeatedly been shown to, even at
early stages of the disease, contain substantial amount of amyloid. By extracting all rows
corresponding to a PCC ROI (manually defined using the Human Brain Atlas [153]), the
voxels correlating with that region (implicitly, voxels correlating with amyloid) were iden-
tified. This method uses the a priori assumption that the PCC contains a high amyloid load
and can be used as a seeding region. It is therefore referred to as the clustering procedure
using an a priori assumption.
Clustering without a priori assumption For simplicity, let the stacked 3D parametric
images be ordered so that the firstNHC images are from control subjects, and the remaining
NAD images are from AD patients. Then, all voxels affected by amyloid will display a
"bump" in BPND in the transition between the groups. The size of the bump defines the
“effect size” between the two groups, as illustrated in figure 12. The biological variability
and random noise present in the images result in that voxels that display a non-zero effect
size (i.e., voxels in which the AD group has a non-negligible load of amyloid) have a
higher correlation to other amyloid-affected voxels, than the corresponding correlations
among non-amyloid voxels as shown in figure 13 (please see the appendix of study V for a
more thorough discussion). By identifying the voxels with the highest average correlation
to other voxels, the voxels associated with a non-negligible effect size can be identified
without any a priori assumption. In practice this was performed by setting a very high
threshold θ for which entries to keep in M, and then averaging all rows corresponding to
brain tissue voxels. In the resulting vector, the i:th component corresponded to the average
correlation between voxel i and all voxels for which that particular correlation was ≥ θ.
The vector was then remapped to image space, where all voxels > 0 were set to 1, and
constituted the final cluster.
Separation of amyloid positive from negative individuals The hypothesis in this project
was that the identified clusters could improve the separation between amyloid positive and
amyloid negative individuals. Two different separation approaches were evaluated for this
purpose, either based on actual BPND values or on the spatial distribution of high amyloid-
β voxels. Separation based on BPND values was simply performed by calculating the
average BPND inside the cluster for each subject. Separation based on spatial agreement
was more complex and was performed as follows.
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Figure 12. Illustration of two voxel curves x and y. The correlation between them will depend on their
respective effect size α and noise levels ε.
First, the BPND values in each parametric image were normalized, so that the max-
imal voxel value was set to 100 and all other voxels were scaled accordingly. Second, the
distribution of normalized BPND was visualized in a histogram and a threshold separating
the AD group from the control subjects was identified. This threshold can be interpreted
as "the value above which a voxel is considered a high BPND voxel, expressed as the per-
centage of the maximal BPND value for that subject". Consequently, for each subject, a
set of the voxels was classified as high BPND voxels. The separation was then performed
by comparing the spatial distribution of the high BPND voxels to the spatial distribution of
the voxels included in the cluster. More specifically, the fraction of voxels in the cluster
corresponding with high BPND voxels was calculated for each individual.
This study only encompasses AD patients and control subjects. For such individuals,
the classifier should generate a large separation between the groups to minimize erroneous
classifications and maximize the margins. To evaluate the performance of the classifier,
a separation distance D between groups x and y was calculated as the distance between
one SD below the average of the higher group and one SD above the average of the lower
group, expressed as a fraction of the maximal range of the data, i.e.
D =
(y¯ − σy)− (x¯+ σx)
max(y)−min(x) , (22)
where y¯ > x¯.
Can the method be applied to other disorders and biomarkers? With regard to the
Clustering without a priori assumptions described above, an interesting question is whether
the method can be applied to identify other types of pathological networks, with other effect
sizes and studied with other radioligands. To assess the question, a simulation experiment
33
Figure 13. Calculation of the pearson product-moment correlation coefficient for a large number of voxel
curves with different effect sizes and noise levels. Low noise levels and high effect sizes yield high correla-
tions. Thus, by extracting the voxels with high correlations, the voxels with large effect sizes are identified.
was conducted, in which the voxel-wise connectivity was investigated under varying effect
sizes and noise levels. Based on these simulated data, a critical effect size was established
for each noise level. The critical effect size indicates the smallest possible effect size needed
between patients and controls in order for the method to detect a connectivity pattern.
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4 RESULTS AND DISCUSSION
4.1 Overview
In this thesis, several algorithms have been developed, implemented, and evaluated. The
first study evaluated the difference in quantitative outcome measures between the HRRT
and a lower resolution system, the HR system. In addition, the effect of correcting the
data for PVE was investigated. In study II, a method to quantify radioligand binding in the
small nuclei of the brainstem was developed, and evaluated using both HR and HRRT data.
In study III, two automated methods for the definition of ROIs were evaluated, allowing
for faster and more objective analysis of PET data. In study IV, a method to estimate the
image-derived arterial input function was developed and validated. The performance of the
method was compared to that of three previously published methods. Finally, in study V,
the same method used in study IV was adapted and applied to PET measurements using
radioligands that bind to amyloid-β, with the aim of classifying subjects based on their load
of amyloid.
4.2 Section 1
4.2.1 Study I, Comparison of the HR and the HRRT PET systems
As described in section 1.4.2, the BPND values measured in the HRRT system should be
higher than those obtained in the HR system due to higher resolution and lower PVE. Study
I confirmed this notion for the frontal cortex and the whole GM. Although there was a trend
towards higher binding potential measured with the HRRT in several of the other regions
examined, the difference between the systems was not statistical significant (see figure 14).
One possible explanation is that the effect of improved resolution is primarily manifested
in rather small regions (see section 1.4.2 for more details). With the exception of the ven-
tral midbrain and the dorsal brainstem, it is therefore possible that the ROIs included in
study I were too large for the effect of improved resolution to become prominent. How-
ever, as described in section 1.4.3, traditional ROI-based quantification is not suitable for
such small ROIs using the HRRT, due to the high voxel-to-voxel noise level. Thus, no
statistically significant difference was observed in the ROIs for which we had anticipated a
large difference between the systems. This observation became the motivation for study II.
The agreement between the systems increased after the data were corrected for PVE
using the Meltzer and Müller-Gärtner methods. In particular, the very good agreement
between the two systems was observed in cortical regions after correction with the Müller-
Gärtner method (Figure 15). This increased agreement provides further support for the
applicability of PVE correction techniques, since it can be assumed that the outcome mea-
sures from both systems were brought closer to the (unknown) true value. However, PVE
correction introduces assumptions that should considered before the algorithms are applied.
For instance, the Müller-Gärtner algorithm assumes that radioligand binding in the whole
WM can be approximated by the average value obtained from an isolated portion of the
centrum cemiovale. Violation of this assumption may lead to underestimation of binding
in the WM portion of the subcortical regions, and thus underestimation of the contamina-
tion from WM to GM, and consequently resulting in an overcorrection of the data.
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Figure 14. BPND measured in the HR and HRRT PET system for regions of different size and different
5-HTT density.
4.2.2 Study II, Measurement of serotonin transporter in the brainstem
To estimate the optimal parameter values for applying WAPI on HRRT data, regionalBPND
was estimated in one small and one large ROI using both WAPI and conventional ROI anal-
ysis (see section 3.7.1 for details). The parameter combination providing the best agree-
ment between the two methods was selected for further analysis. The optimal parameter
combination was found to be a filter kernel length value of 16 and a decomposition depth
of 3, as shown in figure 16.
This parameter combination provided parametric images with high recovery and con-
trast. In particular, a clear visual difference was observed in the signal originating from
raphe nuclei between the HR and the HRRT systems, as can be seen in figure 17. The
semiautomatic ROI delineation procedure enabled definition of small and accurate ROIs
for the superior colliculi, the ventral midbrain, the dorsal raphe nucleus, and the median
raphe nucleus. For the more caudal raphe magnus and raphe obscurus, the BPND values
were too low for the method to provide continuous ROIs. The two nuclei were therefore
combined into a single caudal raphe ROI. The ROI delineation procedure is explained in
section 3.7.2.
In each of the structures examined, the BPND estimated using the HRRT was signif-
icantly higher than the corresponding values obtained from the HR system. On average,
the HRRT consistently provided approximately 30-40% higher BPND values than the HR,
in all of the ROIs examined. In addition, the difference between the systems was not de-
pendent on the threshold used in the ROI delineation procedure. An interesting question is
whether it is possible to relate the difference in BPND between the two systems to measure-
ments of their respective resolutions. One possibility is to assume that, for each structure
examined, there exists a true, but unknown BPND value, and that the measured BPND
value in each structure, (BPHRND and BP
HRRT
ND , respectively) is proportional to the true value
multiplied by the recovery coefficient of the system,{
BPHRND ∝ BP trueND · RCHR
BPHRRTND ∝ BP trueND · RC PSFHRRT
, (23)
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Figure 15. Scatterplot of BPND measured in the HR and HRRT before and after PVE correction. In a and
c, only the HR data are corrected for PVE, whereas in b and d, both HR and HRRT data are corrected. Good
agreement between the systems was found in cortical regions after the PVE correction approach proposed by
Müller-Gärtner et al. was applied to both systems (b).
where RC denotes the recovery coefficient for each system. This assumption can be moti-
vated by considering thatBPND = DVR−1 and that the cerebellar TAC is rather unaffected
by PVE. Since it is the same individual measured in both system, the unknown parameter
BP trueND can be substituted from equation 23. Rearrangement leads to
BPHRND
BPHRRTND
=
RCHR
RCHRRT
(24)
In a previous paper, Varrone et al. showed that the recovery coefficient for the HRRT
system (including PSF modeling) was approximately 0.81 (RC PSFHRRT ≈ 0.81) in a 10 mm
sphere [19]. To our knowledge similar measurements have not been performed for the HR
system. The RC for its predecessor, the ECAT EXACT 922, has previously been estimated
as 0.5 (RC EXACT922 ≈ 0.5) [158]. In addition, the recovery coefficient of the HRRT
system without PSF-modeling has been estimated as 0.6 (RC noPSFHRRT ≈ 0.6) [19, 27]. It is
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Figure 16. Percent difference between BPND estimated using graphical analysis and WAPI in (a) frontal
and temporal cortices, and (b) dorsal brainstem. The transparent mesh illustrates identity between the two
methods. The optimal combination of parameter values for the filter kernel length and decomposition depth
was 16 and 3 (arrows).
reasonable to assume that
RC EXACT922 ≤ RCHR ≤ RC noPSFHRRT , (25)
and thus, 0.5 ≤ RCHR ≤ 0.6. Inserting this range of values for RCHR, together with
RC PSFHRRT ≈ 0.81 in the right hand side of equation 24, it is predicted that the ratio of BPND
measured between the HR and the HRRT system should be≈ 0.7. The corresponding ratios
using the measured BPND values for each system were: 0.75 for the ventral midbrain, 0.74
for the superior colliculi, 0.73 for the dorsal raphe, 0.69 for the median raphe, and 0.74
for the caudal raphe. This agreement provides support for the notion that the dominating
portion of the difference in BPND measured between the two systems are primarily caused
by their disparate resolutions.
To conclude, the method in this study provided significantly higher BPND values for
HRRT data than for HR data. The difference between the systems was not dependent on the
threshold used to define the ROI. A relatively small intersubject variability in the estimates
of BPND was obtained using this method. Altogether, it can be concluded that the method
developed in this study allows for improved mapping and quantification of the density of
5-HTT in the brainstem.
4.3 Section 2
4.3.1 Study III, Evaluation of FreeSurfer and AAL for automatic delineation of
ROIs
The purpose of study III was to evaluate the feasibility of using the AAL template and
the FreeSurfer package to delineate ROIs for PET data analysis. Since manual delineation
is considered the gold standard, regional outcome measures obtained using the automated
methods for ROI delineation were compared to those obtained using manually delineated
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Figure 17. Parametric images of BPND using HR and HRRT data for two subjects. A distinct difference in
recovery between the two systems is visible in the small 5-HTT-rich brainstem regions. For each subjects,
the ROIs obtained from the semiautomatic ROI delineation procedure are superimposed on the T1-weighted
MR images.
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ROIs. The outcome measures used were BPND for [11C]AZ10419369, and DVR for
[11C]AZD2184.
Figure 18. Scatter plot of DVR estimated with manual (x-axis) and automated (y-axis) ROIs for
[11C]AZD2184 data. a: HR, and b: HRRT data.
In general, the agreement in outcome measures between automated and manual ROIs
was satisfactory. Figure 18 and 19 show the scatterplots between outcome measures ob-
tained with automated and manual methods, for both HR and HRRT data. As shown in the
figure, there is general agreement between the methods, but there are also some regions in
which a substantial difference between outcome measures occurs.
The regions with a systematic difference between automated and manual ROIs in-
clude caudate nucleus, hippocampus, amygdala, posterior cingulate cortex, and dorsome-
dial prefrontal cortex. A general cause for the discrepancy between automated and manual
ROIs is that the automated ROIs were significantly larger than the manually defined coun-
terparts. As a consequence, the automated methods lack the buffer zones which are typi-
cally drawn by a manual rater, to avoid spill-over of radioactivity between the ROIs. The
effect becomes prominent in regions adjacent to structures with high levels of radioligand
binding. For instance, in the [11C]AZ10419369 dataset, BPND values in amygdala and
hippocampus were overestimated using automated ROIs. The amygdala is a small region
located near basal forebrain structures that are associated with a high density of 5-HT1B
receptors [144], while the hippocampus is located adjacent to relatively high density struc-
tures such as pallidum. BPND estimated in these regions were consequently overestimated,
possibly due to the lack of buffer zones.
Another interesting region to highlight is the caudate nucleus. BPND estimated in the
caudate was systematically lower for both AAL and FreeSurfer than for the manual ROIs.
The discrepancy between the automated and manual ROI for the caudate was primarily
due to different anatomical definitions of the structure. The automated ROIs tended to
cover the whole structure, whereas for the manually defined ROI of the caudate, only the
ventrolateral part of the structure is traditionally drawn to avoid spill-out of radioactivity
into the ventricles.
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Figure 19. Scatter plot ofBPND estimated in manual (x-axis) and automated (y-axis) ROIs for
[11C]AZ10419369 data. a: HR, and b: HRRT data.
Is it possible to use an automatically defined reference region? A secondary aim of
this study was to evaluate whether a modified version of the cerebellar ROI incorporated
in AAL could be used as a reference region (similar evaluation was not performed for
FreeSurfer since the cerebellar ROI in FreeSurfer deviated substantially from the manually
defined version). The AAL cerebellar ROI was trimmed and cropped so that it resembled
the manual counterpart as much as possible. Still, the outcome measures obtained using
the automated reference region were consistently biased. Moreover, opposite biases was
observed for the two radioligands; higher regional DVR was observed for [11C]AZD2184
and lower BPND was observed for [11C]AZ10419369. For [11C]AZD2184, the larger au-
tomated cerebellum includes voxels close to the border of the fourth ventricle, and thus
experiences a substantial spill-out of radioactivity. For [11C]AZ10419369 however, this ef-
fect is compensated by the inclusion of the vascular tissue from the venous sinuses, which
have been reported to have a high density of 5-HT1B receptors [146]. The bias introduced
by using the automatic reference region lowered the accuracy of the regional outcome mea-
sures. It can be concluded that, the AAL cerebellar ROI used in this study should not be
used.
FreeSurfer or AAL? Despite the higher level of complexity of FreeSurfer, both meth-
ods showed similar accuracy in the estimates of regional outcome measures. The choice
of which method to use is therefore dependent on other factors, such as the necessity of
fast analysis as provided by the AAL template, or the need for anatomically detailed ROIs
as provided by FreeSurfer. As a final remark, although it is not apparent from the data
included in this study, FreeSurfer tended to provide more reliable segmentation of subcor-
tical structures in subjects with severe atrophy than the AAL method, which in some cases
included ventricular voxels in striatal ROIs.
41
4.4 Section 3
4.4.1 Study IV, Application of the pairwise correlation method to obtain image-
derived arterial input function
In this study, the Pair-Wise correlation (PWC) method (see section 3.8) was applied to
derive arterial input functions directly from PET images. For this purpose, 6 PET mea-
surements acquired using the GABAA radioligand [11C]flumazenil, and 6 measurements
acquired using the 5-HT1B receptor radioligand [11C]AZ10419369 were used. The perfor-
mance of the PWC method was compared to that of Chen’s method [108], Mourik’s method
[110], and Naganawa’s method [113]. The PWC method enabled identification of voxels
Figure 20. Clusters derived from two representative subjects using the PWC method in order to identify
voxels with blood-like behavior. a: [11C]flumazenil, and b: [11C]AZ10419369.
displaying blood-like behavior for all subjects. Two representative clusters are shown in
figure 20. Applying the clusters to the dynamic PET measurements together with the cor-
rection scheme (i.e., correcting the first 3 minutes for spill-out of radioactivity using the
Rousset method reduced to one compartment and tail scaling to the remaining part of the
curve) provided blood curves which were in good agreement to the measured radioactiv-
ity levels in arterial blood. Consequently, the regional VT values obtained using the PWC
method were well matched to those obtained using the measured arterial input function.
Using the PWC method, the percent difference was on average ∼ 3%.
As can be seen in figure 21, the performance of the PWC method was similar to or
better than the other three methods in terms of its ability to generate VT values similar to the
measured input functions. Naganawa’s method, which is based on independent component
analysis (ICA), provided blood curves with negative values for all subjects measured with
[11C]flumazenil and provided high variability in the estimates for VT of [11C]AZ10419369.
Considering the complex nature of ICA, it is likely that Naganawa’s method could perform
better if it were tuned for each radioligand used [159]. In this study however, the method
was applied as described in the original publication [113].
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Figure 21. Scatter plot showing the agreement between VT obtained using image-derived input functions
(x-axis) versus measured input functions y-axis for a: [11C]flumazenil, and b: [11C]AZ10419369. Note that
VT derived using Naganawa’s method is not included in a, since it provided IDIFs with negative values for all
subjects measured with [11C]flumazenil. For both radioligands, VT derived using the PWC provided slopes
closer to 1 and intercepts closer to 0.
Mourik’s and Chen’s methods both overestimated regional VT values in the sub-
jects measured with [11C]flumazenil by approximately 20% (corresponding value using
the PWC method was 7%). This overestimate probably results from the fact that both
Chen’s and Mourik’s methods only take the initial part of the measurement into account
when defining the carotid ROI, allowing for inclusion of voxels affected by noise in the
late part of the measurement.
In this study, the Logan plot was used to estimate regional VT -values (see description
in 1.3.6). This introduces some limitations in the interpretations of the results. In the Logan
method, calculation of VT is based on the AUC of the input functions, and is less sensitive
to erroneously estimated initial peaks. All of the methods evaluated in this study displayed
some variability in the estimates of the peak radioactivity. However, this variability is to
some extent suppressed in the estimates of regional VT -values. The early peak of the blood
curve primarily affects the rate of influx of radioactivity across the blood-brain barrier,
which is reflected by the rate constant K1. Uncertainty in the estimate of the peak signal
may therefore introduce an uncertainty in the estimates ofK1. Thus, the methods evaluated
in this thesis should be used with caution in situations where changes in blood flow are
expected.
There are other consequences of using quantification methods which emphasizes the
AUC of the input function. In this study, the [11C]flumazenil dataset showed worse perfor-
mance for the Chen’s, Mourik’s, and the PWC method as compared to [11C]AZ10419369.
Interestingly, the [11C]flumazenil also showed significantly lower AUC of the standardized
uptake value of the input functions than [11C]AZ10419369 datasets (p = 8.2 · 10−4, two-
tailed t-test). Thus, for [11C]flumazenil, small fluctuations in the input functions represent
a larger proportion of the total AUC than for [11C]AZ10419369, which makes VT obtained
from IDIF more sensitive to noise and to other factors affecting the image quality (such as
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the image reconstruction settings).
As a final remark, although it seems likely that the PWC method would work for a
larger array of radioligands, it needs to be evaluated for each one separately. For example,
radioligands such as [11C]MADAM and [11C]DASB, which bind to the serotonin trans-
porter, might provide low signal from the blood due to the prevalence of 5-HTT in lung
tissue and to the large distribution volume in the body. Thus, the carotid-to-background ra-
tio is reduced, making the signal from blood hard to distinguish from tissue signal. To our
knowledge, no method for extracting IDIF has been shown to work for these radioligands,
possibly due to low signal-to-noise ratio.
4.4.2 Study V, Application of the pairwise correlation method to cluster voxels with
amyloid
In this study, it was hypothesized that the PWC method could be applied to identify a dis-
ease specific spatial pattern of amyloid, which characterizes the distribution of radioligand
binding in a group of AD patients. This disease specific pattern, or cluster, was identified
by investigating how the voxels correlated across a group consisting of 10 AD patients and
6 controls examined with [18F]AZD4694. More specifically, two different approaches to
define the cluster were evaluated. The first approach was based upon the assumption that
in AD patients the posterior cingulate cortex (PCC) contains a high level of amyloid. Thus,
all voxels correlating with the voxels in the PCC were identified. The resulting cluster is
shown in figure 22a. The voxels identified were located in regions which have previously
been shown to be affected by amyloid in traditional ROI-based analysis.
Using PCC as a seeding region is a valid approach for the present purpose. However,
the use of a seeding region introduces methodological limitations. For other applications, it
is possible that no suitable seeding region, i.e., a brain region displaying the known signal
of interest, can be identified. Therefore we also investigated the possibility of identifying
the disease specific amyloid pattern without any a priori assumptions. Voxels experiencing
an effect size between the patients and controls correlate with other voxels displaying a
non-zero effect size. Due to the presence of noise and biological variability in the data,
the correlation coefficient between voxels with effect size is higher than the correlation
coefficients between voxels without effect size. In other words, the correlation coefficient
between two amyloid voxels will be higher than the correlation coefficient between two
non-amyloid voxels (a more thorough discussion on this matter is given in the appendix
of study V). Thus, by finding the voxels that have a high average correlation coefficient to
other voxels, the amyloid voxels are identified without the need of a seeding region. The
cluster obtained in this manner is shown in figure 22b.
The voxels included in these clusters reflect the spatial distribution characterizing
AD, and can thus be used to create a classifier that clearly separates patients from controls.
The classification can for instance be based on calculating the average BPND inside the
cluster for each individual. Using this approach and the clusters shown in figure 22 for the
PET images acquired with [18F]AZD4694 and an additional dataset consisting of 16 PET
images acquired with [11C]AZD2184, we found complete separation between controls and
AD patients as shown in figure 23a and b. For both clusters, the separation distance (equa-
tion 22) was approximately 30% for the [18F]AZD4694 and 50% for the [11C]AZD2184
datasets.
Although the AD group in general has higher BPND values than the control sub-
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Figure 22. Clusters of amyloid obtained using the PWC approach. a: Posterior cingulate cortex (blue) was
used as a seeding region, and b: the voxels having the highest average correlation to other voxels (i.e., no
seeding region).
jects, interindividual differences in the actual BPND values are expected. These differ-
ences can cause overlaps between AD patients and healthy individuals who have low but
non-negligible levels of amyloid concentration [138–140]. Rather than measuring the ac-
tual BPND, an interesting alternative is to compare the individual spatial distribution of the
voxels affected by a high amyloid load to the spatial distribution of the voxels assumed to
characterize the disease (i.e., the clusters in figure 22). The separation between the groups
obtained using this approach is shown in figure 24, and the corresponding separation dis-
tance was approximately 50% and 70% for the [18F]AZD4694 and the [11C]AZD2184
datasets, respectively.
The two methods described above provided a convincing separation distance between
the AD patients and the control subjects. This large separation distance suggests that the
measurement is restricted to the regions in the brain which are found to characterize the
disease. Furthermore, focusing the classifier on the spatial distribution of amyloid rather
than the actual BPND values provided a substantial increase in the separation between the
groups. Consequently, the spatial distribution of amyloid is a more powerful measurement
for group separation. This becomes particularly interesting when considering that a distinct
pattern of amyloid has been shown to affect the extent of cognitive decline. These observa-
tions provide further support for the theory that it is not amyloid per se that characterizes
AD, but rather, amyloid in certain vulnerable brain regions. These brain regions do not
necessarily adhere to the conventional definition of brain regions, and thus, the separation
is improved when conventional ROIs are not used.
So far, this method has only been applied to a group of healthy subjects and AD
45
Figure 23. Separation of individuals based on the average BPND inside the clusters obtained a: using PCC
as a seeding region, and b: without seeding region.
Figure 24. Separation of individuals based on the spatial similarity between the distribution of high BPND
voxels and the clusters, obtained a: using PCC as a seeding region, and b: without seeding region.
patients. Its predictive accuracy on subjects having prodromal stages of AD is therefore
not assessed. Still, increased separation distance at least reduces the risk of misclassifying
patients associated with low amyloid signal as healthy. In addition, since the formation of
amyloid plaques appears to follow a rather well-characterized spatial pattern as the disease
progresses, it is possible that the cluster is gradually filled by high BPND voxels. If this
is true, intermediately filled cluster (e.g., subjects in between the two extremes shown in
figure 24) may be interpreted as an indicator for progression towards onset of AD, and thus
serve as a marker for being at risk of developing the disease.
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Can the method be applied to other disorders and biomarkers? The Clustering with-
out a priori assumptions method relies on the assumption that correlations among voxels
showing only background signal will be lower than correlations among voxels associated
with the specific signal, due to the presence of noise and biological variability in the data.
In a simulation experiment, the correlation coefficient between a large number of voxel
curves with different effect sizes and noise levels was calculated. For each voxel, the aver-
age correlation to other voxels is shown in figure 25 for three different values of θ. In figure
25, a unique combination of effect size and noise level is assigned to each small square (or
"scenario", 20 × 20 pixels). All scenarios correspond to an effect size > 0, and thus each
scenario corresponds to a pathological state. If > 95% of the pixels in a scenario were cor-
rectly classified as displaying a "disease specific" signal, the corresponding condition (i.e.,
effect size and noise level) was considered "manageable". All scenarios associated with
manageable conditions are marked in white in the right column of figure 25.
Figure 25. Results from the simulation showing the voxels displaying high average correlation to other
voxels, for various effect sizes and noise levels. a: θ = 0.90, b: θ = 0.95, and c: θ = 0.985.
The simulation illustrates that it is possible to derive a cluster without using a seeding
region, if the effect size is larger than a critical value, which in turn depends on the value
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of θ. However, suitable values for θ are decided by the size of M, and cannot be predicted
in advance. Thus it is not straight-forward to predict the performance of the method when
applied to other radioligands and biomarkers. Nevertheless, for each noise level, there ex-
ists a critical effect size below which the algorithm will not work. Although the simulation
experiment suggests that the method can be generalized, the performance of the method
applied in situations with suitable noise levels and effect sizes remains to be elucidated.
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5 CONCLUSIONS
The focus of this thesis has been on methodological advancements of PET data quantifica-
tion. The findings are summarized below.
5.1 Section 1
• The higher resolution of the HRRT as compared to the HR system is to some extent
reflected in the higher outcome measures. Correcting the data for partial volume
effects increases the agreement between the systems.
• In the small brainstem regions, we expected that the difference between binding po-
tential estimated in the two systems would be substantial. Instead we found no differ-
ence between the systems and a high intersubject variability. This unexpected finding
probably results from the high noise levels of the HRRT which prevent accurate mea-
surement of radioligand binding using conventional ROI-based analysis.
• Wavelet-aided parametric imaging, in combination with HRRT, can provide images
with suppressed noise levels and with sufficient resolution to accurately resolve small
brainstem structures. This procedure, when used with a semi automatic method to de-
rive small brainstem ROIs, enabled detailed mapping of serotonin transporter density
in several small brainstem structures. This procedure provides more robust estimates
of BPND than conventional ROI-based analysis. In addition, the difference in BPND
between the HR and HRRT PET systems was significant and mainly attributable to
their disparate resolutions.
5.2 Section 2
• Both the AAL and FreeSurfer can be used to automatically delineate ROIs for the
quantification of PET data obtained using the two radioligands [11C]AZD2184 and
[11C]AZ10419369.
• Since the performances of AAL and FreeSurfer are similar, the choice of the method
can be based on other situational factors, such as the need for short processing time
as provided by AAL, or the need for more detailed ROIs as provided by FreeSurfer.
5.3 Section 3
• The pairwise correlation approach can be used to define ROIs for the carotid arteries,
using the radioligands [11C]flumazenil and [11C]AZ10419369. After applying the
PWC method, compensating for spill-out of radioactivity, and applying tail-scaling,
the image-derived arterial input functions were in good agreement with the measured
input functions.
• The developed method performed similarly or better than three previously suggested
methods, published by Chen et al., Mourik et al., and Naganawa et al.
• The PWC method can also be applied to cluster voxels associated with amyloid load.
When the PWC method was applied to a group of AD patients and healthy controls, a
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common pattern of amyloid-β was identified, either by using the posterior cingulate
cortex as a seeding region or by finding the voxels with the highest connectivity to
other voxels.
• The PWC method is generic and can likely be successfully applied to other radioli-
gands and biomarkers.
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6 FUTURE PERSPECTIVES
High resolution PET imaging or hybrid systems? During recent years, there has been
a trend towards building hybrid systems such as PET/MR [160–162]. A hybrid system is
in theory the best of two worlds; high resolution MR images provide detailed structural
information, and high sensitivity PET images provide the ability to accurately quantify
radiotracer distribution. However, the hybrid systems developed so far for human brain
imaging have resolutions comparable to that of the HR system [161] because modifications
in instrumentation are required for the two modalities to be integrable. The results in study
I suggest that no major implications on conventional ROI-based analysis are to be expected
from this reduction in resolution. However, the results of study II indicate that accurate
quantification of small brain structures, such as the raphe nuclei, might not be possible
using the lower resolution hybrid systems. Since the raphe nuclei are not clearly detectable
on MR images, hybrid systems provide limited value for that particular application.
Quantifying radioligand concentration in small brain structures. The methodology
for quantification of radioligand binding in the small brainstem nuclei described in study II
is limited by the volumetric assumption regarding the volume of the nucleus. For healthy
individuals, the assumption may well be valid, but not for patients with expected neurode-
generation, such as patients with Parkinson’s disease. A potential workaround is to use
the proposed method to generate an ROI-template for the brainstem in a generic space and
then spatially warp it to parametric images of the patients. Although particular attention
needs to be paid to the spatial normalization, the procedure may enable quantification of
serotonin transporter in the brainstem of both patients and healthy subjects.
Automated or manual ROIs in the future? Continuous improvements in image regis-
tration and segmentation algorithms are expected, which will implicitly also improve the
accuracy of template-based methods for definitions of ROIs. The future of PET applied to
neurological sciences are likely not to include any manually defined ROIs at all, consid-
ering the undisputable benefits associated with automated methods. In the years to come,
publications utilizing a large amount of pooled PET data quantified using automated ROIs
can be expected, similar to the recently published work by Savli et al. [163] including
∼100 PET measurements. Using PET image databases of such proportions, many interest-
ing biological findings can be anticipated.
Correction for PVE in the future. With the introduction of automated methods for ROI
definition, a more routine use of the Rousset PVE-correction scheme can be anticipated in
the near future. Theoretically, the smaller the ROIs, the weaker is the assumption regarding
homogeneous binding inside the ROI. The extreme case is to apply the correction to indi-
vidual voxels rather than ROIs. Such procedure would allow for using PSFs with increased
FWHM for voxel close to the edges to account for the varying resolution in the FOV. Al-
though the method is today too computationally demanding, it may well be a versatile
option in the future.
Image-derived input function – challenges and opportunities. Numerous methods to
estimate the image-derived input function have been suggested. Alternatives to complex
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methods to estimate the IDIF are population-based input functions [164] and simultane-
ously estimated input functions, i.e., methods simultaneously estimating the parameters of
the input function and the rate constants of several brain regions [165]. Unfortunately, the
PET system cannot distinguish between radioactivity concentration from the parent radioli-
gand and its metabolites. Blood samples are therefore still needed even for a perfect method
of estimating the IDIF. Using blood samples for scaling the blood curve is not necessarily
a drawback of the method, since the data will be available anyway. Still, the invasiveness
can be reduced if venous samples can be used for scaling rather than arterial samples. An
interesting alternative is to predict the arterial radioligand concentration based on venous
measurements [166], similarly to what has been done for nicotine studies [167].
Amyloid clustering. In general, with increased computational power and memory capac-
ities, more voxel-based multivariate statistical analysis of PET data for improved diagnosis
of AD can be anticipated. Combining cognitive tests and various biomarkers have previ-
ously been shown to improve the prediction rate of AD [168], and thus we can expect more
studies including both amyloid PET, as well as volumetric measurements of the hippocam-
pus and concentration of amyloid-β in CSF. The methodology described in study V has the
benefit that such external parameters can be easily incorporated, by simply extending the
matrix by one row and column per measure.
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